Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

https://leipzig-interventional-course.live/

8 events

Wednesday, August 26th: 16:00 - 17:30, https://leipzig-interventional-course.live/

LINC LIVE webinar – Complex femoropopliteal lesions & new treatment options – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Sven Bräunlich, Miguel Montero-Baker, Jim Melton, Tom Davis
1. With continuous live case transmission from University Hospital Leipzig, Germany Long SFA occlusion to P2
2. 16:00 - 16:03
  
  Introductions
3. 16:03 - 16:08
  
  Challenges of complex femoropopoliteal lesions & disease patterns – how to approach & crossing strategies
4. 16:08 - 16:13
  
  Optimal strategies for vessel preparation
5. 16:13 - 16:18
  
  Refining atherectomy with Rotarex
6. 16:18 - 16:23
  
  Real World Results, The Leipzig Experience
7. 16:23 - 17:30
  
  Discussion – Q & A – Voting
Wednesday, September 2nd: 16:00 - 17:30, https://leipzig-interventional-course.live/

LINC LIVE webinar – Advanced concepts for complex femoropopliteal obstructions: Differential use of drug-eluting devices and the role of vessel preparation – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Koen Deloose, Yann Gouëffic, Antonio Micari, Sabine Steiner, Martin Andrassy, Angelo Cioppa
1. With continuous live case transmission from University Hospital Leipzig, Germany Recanalisation of a challenging multilevel peripheral lesion
2. Latest information from the Ranger DCB programme: How does low-dose DCB technology COMPARE?
3. Insights on ELUVIA from the IMPERIAL-trial and beyond: When to prefer a stent-based approach?
4. SFA vessel preparation with the JETSTREAM atherectomy: Tips, tricks, and clinical outcomes
5. Atherectomy in distal disease and in-stent restenosis: expanded use learnings
6. Discussion – Q & A – Voting
7. https://leipzig-interventional-course.live/
Wednesday, September 9th: 9:00 - 12:00, https://leipzig-interventional-course.live/

LINC LIVE webinar – Lower limb treatment algorithm – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Sven Bräunlich, Weihao Shi, Zhi Hui Dong, Yongjun Li, Dongming Zhang
1. With continuous live case transmission from University Hospital Leipzig, Germany – Complex lower limb cases
2. Treatment-algorithm femoro-popliteal artery
3. Embolic protection in the peripherals
4. Discussion – Q & A – Voting
5. https://leipzig-interventional-course.live/
Wednesday, September 16th: 16:00 - 17:30, https://leipzig-interventional-course.live/

LINC LIVE webinar – From the front line: strategies for limb preservation and reducing reintervention – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Marianne Brodmann, Peter Schneider, Jos van den Berg, John Laird
1. With continuous live case transmission from University Hospital Leipzig, Germany
2. Introduction
3. Patients at risk for restenosis in today’s environment: what is your algorithm for reducing re-intervention?
4. Discussion
5. Scientific evidence for the treatment of anatomically challenging lesions
6. Discussion
7. Preserving the native vessel for future treatment options
8. Discussion
9. Algorithm for below the knee disease when stenting is not an option
10. Closing
11. https://leipzig-interventional-course.live/
Wednesday, September 23rd: 16:00 - 17:30, https://leipzig-interventional-course.live/

LINC LIVE webinar – Use of Rotarex®S and DCB for treating ISR around the world – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Sven Bräunlich, Steven Kum, Romaric Loffroy, Chuan-Jun Liao
1. Evolution and challenges of ISR – how to approach
2. Technical aspects of Rotarex®S device
3. With continuous live case transmission from University Hospital Leipzig, Germany – SFA ISR
4. Use of Rotarex®S and DCB for ISR: French multicentre experience
5. Use of Rotarex®S and DCB for ISR: Beijing experience
6. Use of Rotarex®S and DCB for ISR: Leipzig experience
7. Panel Discussion
8. https://leipzig-interventional-course.live/
Wednesday, September 30th: 16:00 - 17:30, https://leipzig-interventional-course.live/

LINC LIVE webinar – Achieving confidence and best patients' outcomes for SFA lesions, with the support of your colleagues – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Yann Gouëffic, Manuela Matschuck, Klaus Hertting
1. With continuous live case transmission from University Hospital Leipzig, Germany – Complex treatments – simple decisions
2. Introduction
3. TIPS AND TRICKS FOR BEST INTERWOVEN NITINOL STENT RESULTS
4. My learnings – tips and tricks when starting with Supera
5. Next steps in my Supera experience
6. Using Supera in the most challenging situations
7. Discussion – Q & A – Voting
8. https://leipzig-interventional-course.live/
Wednesday, November 4th: 15:30 - 17:00, https://leipzig-interventional-course.live/

LINC LIVE webinar – Challenging lesions – Advanced technology. Utilising scoring balloons or drug coated technology – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Marianne Brodmann, Michael Lichtenberg, Matthias Ulrich
1. With continuous live case transmission from University Hospital Leipzig, Germany
2. Lutonix BTK registry 2 year follow up – data presentation
3. DCB IDE below-the-knee six-month results with in-depth look at diabetic patients
4. Lesion preparation with scoring technology and using a low profile access sheath in patients with CLI
5. The UltraScore™ focused force PTA balloon: update of a multi-centre registry
6. Discussion – Q & A – Voting
7. https://leipzig-interventional-course.live/
Wednesday, November 25th: 11:00 - 12:30, https://leipzig-interventional-course.live/

LINC LIVE webinar – Challenging lesions and how to approach with advanced technologies – https://leipzig-interventional-course.live/

Moderator:

Dierk Scheinert

Panel:

Sven Bräunlich, Daizo Kawasaki, Andrej Schmidt, Hiroyoshi Yokoi
1. With continuous live case transmission from University Hospital Leipzig, Germany
2. Optimizing vessel preparation and outcomes with debulking techniques
3. Japan update: Optimal strategies for vessel preparation and DCB usage
4. Update on Paclitaxel safety from the results of Japanese patients analysis
5. Discussion – Q & A – Voting
6. https://leipzig-interventional-course.live/

Room 1 - Main Arena 1

21 events

Tuesday, January 28th: 8:00 - 9:30, Room 1 - Main Arena 1

Symposium: Stepping forward: Changing the standard of care in lower limb treatments

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Luis Palena, Yann Gouëffic, Koen Deloose, Erwin Blessing
1. 08:00 - 08:05
  
  Welcome
2. 08:05 - 08:13
  
  Mimetic stent technology – providing safe, sustained, and optimal care
3. 08:13 - 08:38
  
  Live case transmission from Leipzig
4. 08:38 - 08:46
  
  Supersub II – preliminary results
5. 08:46 - 08:54
  
  STELLA Supera – 12-month results revealed
6. 08:54 - 09:19
  
  Live case transmission from Leipzig
7. 09:19 - 09:27
  
  Supera VMI-CFA study – 2-year follow-up, ready to change the standard of care?
8. 09:27 - 09:30
  
  Discussion and conclusion
Tuesday, January 28th: 9:30 - 11:00, Room 1 - Main Arena 1

Latest insights on safety and efficacy of drug-coated devices

Moderator:

Dierk Scheinert, William Gray

Panel:

Hiroyoshi Yokoi, Andrew Holden, Marianne Brodmann, Peter Schneider, Thomas Zeller, Eva Freisinger
1. FOCUS ON PACLITAXEL SAFETY
2. 09:30 - 09:40
  
  The controversy about Paclitaxel safety – where do we stand? A summary of concerns, available data, and open questions
3. 09:40 - 09:45
  
  FIRST TIME DATA RELEASE: In depth independent safety analysis by Syntactx (CRO) of the Lutonix SFA DCB
4. 09:45 - 09:50
  
  FIRST TIME DATA RELEASE: Paclitaxel exposure and dosage of drug-coated balloons for the treatment of PAD: Exploring mortality rates by regions around the globe
5. 09:50 - 09:55
  
  New long-term information on PTX coated DCB: 5-year results from the AcoArt study
6. 09:55 - 10:00
  
  Latest information on long-term efficacy and safety on the Zilver PTX programme
7. 10:00 - 10:05
  
  Mortality after use of Paclitaxel-based devices in peripheral arteries: A real-world safety analysis
8. 10:05 - 10:12
  
  The presence and the future of drug-coated devices: What to expect in the next 5 years?
9. 10:12 - 10:17
  
  Panel discussion
10. FOCUS ON NEW EFFICACY DATA AND NEW APPROACHES
11. 10:17 - 10:22
  
  FIRST TIME DATA RELEASE: COMPARE-RCT of low dose vs. high dose Paclitaxel coated balloons: 1-year results of the full cohort
12. 10:22 - 10:27
  
  FIRST TIME DATA RELEASE: 6-month results from Lutonix SFA Japan PMS update
13. 10:27 - 10:32
  
  FIRST TIME DATA RELEASE: Illumenate 4-year update
14. 10:32 - 10:37
  
  Drug-coated balloon angioplasty of femoropopliteal lesions maintained superiority over standard balloon – 2-year results of the randomized EffPac trial
15. 10:37 - 10:42
  
  RANGER II SFA: Randomized trial of RANGER DCB vs. PTA in the SFA
16. 10:42 - 10:47
  
  The DCB dose difference: A comparison of drug in tissues of different .018 DCBs
17. 10:47 - 10:52
  
  Post-DCB dissection repair: 12-month results from TOBA III
18. 10:52 - 11:00
  
  Discussion and conclusion
Tuesday, January 28th: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: Advanced techniques for the treatment of CLI patients

supported with an educational grant from Philips

Moderator:

Marco Manzi, Jihad Mustapha

Panel:

Konstantinos Stavroulakis, Michael Lichtenberg, Roberto Ferraresi
1. 11:00 - 11:06
  
  The role of advanced imaging in CLI
2. 11:06 - 11:26
  
  Live case transmission from Leipzig
3. 11:26 - 11:32
  
  The role of vessel prep in CLI
4. 11:32 - 11:52
  
  Live case transmission from Bergamo
5. 11:52 - 11:58
  
  DCB in CLI: Rationale and benefit in current times
6. 11:58 - 12:30
  
  Discussion and conclusion
Tuesday, January 28th: 12:30 - 13:25, Room 1 - Main Arena 1

Lunch symposium: Paclitaxel and your practice: Global perspectives

supported with an educational grant from COOK Medical

Moderator:

William Gray

Panel:

Thomas Zeller, Osamu Iida, Robert Morgan, Iris Baumgartner
1. 12:30 - 12:32
  
  Introduction
2. 12:32 - 12:42
  
  How Paclitaxel is perceived in Japan
3. 12:42 - 12:52
  
  Impact of society guidelines in my daily practice
4. 12:52 - 13:02
  
  Applying the guidelines to my treatment algorithm
5. 13:02 - 13:12
  
  Follow the data: Zilver PTX global data analysis
6. 13:12 - 13:17
  
  Overcoming the meta-analysis: Moving forward
7. 13:17 - 13:25
  
  Summary of symposium, discussion, and debate
Tuesday, January 28th: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Optimizing revascularisation in patients with risk factors and complex peripheral arterial lesions

sponsored by Medtronic

Moderator:

Dierk Scheinert, Thomas Zeller

Panel:

Andrew Holden, Giovanni Torsello
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:43
  
  Is there a durable treatment option for challenging lesions? the scientific evidence for drug-coated balloons
3. 13:43 - 13:51
  
  Anatomically challenging lesion locations: What are my treatment options?
4. 13:51 - 14:16
  
  Live case transmission from Bergamo
5. 14:16 - 14:24
  
  Opening your BTK treatment options: Unique tools & techniques
6. 14:24 - 14:49
  
  Live case transmission from Leipzig
7. 14:49 - 15:00
  
  Panel discussion and conclusion
Tuesday, January 28th: 15:00 - 16:30, Room 1 - Main Arena 1

Symposium: AcoArt drug eluting solutions: 5 years safety and effectiveness in FP, latest outcome in BTK

supported with an educational grant from Acotec

Moderator:

Dierk Scheinert, Xin Jia

Panel:

Zhidong Ye, Guanhua Xue, Jun Cheng, Weihao Shi, Wei Wang
1. 15:00 - 15:09
  
  The application of DCB in Type C/D lesion
2. 15:09 - 15:18
  
  Redefining DCB in BTK treatment: 12-month outcomes of AcoArt II study
3. 15:18 - 15:27
  
  Why DCBs should be first line therapy for most femoropopliteal lesions
4. 15:27 - 15:36
  
  DCB in BTK: 12-month results of AcoArt BTK Italy study
5. 15:36 - 15:45
  
  Exploring DCB in TAO
6. 15:45 - 15:54
  
  Distal embolization after DCB – true or false?
7. 15:54 - 16:03
  
  Preliminary experience of using DCB in new indications
8. 16:03 - 16:20
  
  Live case transmission from Leipzig
9. 16:20 - 16:30
  
  Discussion and conclusion
Tuesday, January 28th: 16:30 - 18:00, Room 1 - Main Arena 1

New stent technologies and advanced concepts for implantable vascular scaffolds

Moderator:

William Gray, Koen Deloose

Panel:

Klaus Amendt, Brian DeRubertis, Yann Gouëffic, Osamu Iida
1. 16:30 - 16:37
  
  2-year outcomes from the IMPERIAL randomized study of Eluvia and Zilver PTX
2. 16:37 - 16:42
  
  BATTLE: A RCT comparing bare metal stent vs. Paclitaxel polymer free eluting stent: 2-year outcomes
3. 16:42 - 16:47
  
  ILLUMINA study – 2-year results with a polymer free Sirolimus eluting DES in femoropopliteal arteries
4. 16:47 - 16:52
  
  VaibAhn steNt graft placement for superficial femoral artery disease reQUIring endovaScular tHerapy: Vanquish study
5. 16:52 - 16:57
  
  Increased outward force of self-expanding BMS in the SFA could be a significant risk factor for a restenosis
6. 16:57 - 17:02
  
  Difference in clinical outcomes of low COF stent vs. high COF stent proven in clinical practice
7. 17:02 - 17:22
  
  Live case transmission from Berlin
8. 17:22 - 17:27
  
  FIRST TIME DATA RELEASE: Final results from the LOCOMOTIVE registry using the VascuFlex Multi-LOC stent system in real-world lesions
9. 17:27 - 17:32
  
  TINTIN study: Final 12–month data with the combination of Luminor DCB+SX stent in TASC C and D lesions
10. 17:32 - 17:37
  
  A single-center experience with the Tack endovascular system: Real-world tacking above and below-the-knee
11. 17:37 - 17:42
  
  Dissecting the TOBA data above and below-the-knee: What it means in practice
12. 17:42 - 17:47
  
  Latest updates from the MIMICS clinical programme: Studying BioMimics 3D – The Swirling Flow Stent
13. 17:47 - 17:52
  
  1-year results in unselected, real-world patients with the BioMimics 3D Swirling Flow stent in femoropopliteal lesions: The MIMICS-3D Registry
14. 17:52 - 17:57
  
  Endoluminal bypass in CLI patient: Long term results
15. 17:57 - 18:00
  
  Discussion and conclusion
Wednesday, January 29th: 8:00 - 9:30, Room 1 - Main Arena 1

Optimizing the treatment of BTK vessels in critical limb ischemia

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Dai-Do Do, Francesco Liistro, Matthew Menard, Luis Palena, Jihad Mustapha, Steven Kum
1. 08:00 - 08:05
  
  FIRST TIME DATA RELEASE: Latest 24-month BTK global real-world registry Lutonix DCB outcomes
2. 08:05 - 08:10
  
  FIRST TIME DATA RELEASE: Update on BTK IDE Lutonix DCB – complex patient subset
3. 08:10 - 08:15
  
  FIRST TIME DATA RELEASE: Stellarex in the real-world: Interim look at the BTK cohort
4. 08:15 - 08:20
  
  12-month results from the randomized AcoArt BTK study
5. 08:20 - 08:25
  
  Initial experience with the temporary drug-coated Spur system to enhance drug delivery to the vessel wall
6. 08:25 - 08:30
  
  Small artery disease (SAD) and media artery calcification (MAC) are changing the fate of CLI patients
7. 08:30 - 08:35
  
  FIRST TIME DATA RELEASE: LimFlow pDVA for no-option CLTI: The ALPS registry data at 2 years
8. 08:35 - 08:55
  
  Live case transmission from Leipzig
9. 08:55 - 09:00
  
  Optimizing below-the-knee angioplasty: Dissections matter
10. 09:00 - 09:05
  
  Repairing BTK dissection: Results from the TOBA II BTK pivotal study
11. 09:05 - 09:10
  
  Intra-procedural extra-vascular ultrasound prevents early and late failures in BTK
12. 09:10 - 09:15
  
  High pressure non compliant POBA in real-world CLI – 12-month results from the JADE registry in Singapore
13. 09:15 - 09:20
  
  The advantages of using perfusion angiography during CLI procedures
14. 09:20 - 09:25
  
  Tissue perfusion assessment drives and predicts clinical success in severe CLI: experience from a 330 patient study
15. 09:25 - 09:30
  
  Discussion and conclusion
Wednesday, January 29th: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Drug eluting technologies for PAD: From fundamentals to future

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert, Thomas Zeller

Panel:

Ravish Sachar, Marianne Brodmann, Andrew Holden, Giovanni Torsello
1. 09:30 - 09:32
  
  Introduction
2. 09:32 - 09:42
  
  Fundamentals of drug coated balloons
3. 09:42 - 09:52
  
  Lessons from Ranger SFA II RCT (Ranger DCB vs. PTA)
4. 09:52 - 10:02
  
  Lessons from COMPARE RCT (Ranger DCB vs. IN.PACT DCB)
5. 10:02 - 10:27
  
  Live case transmission from Leipzig
6. 10:27 - 10:37
  
  Fundamentals of drug eluting stents
7. 10:37 - 10:47
  
  Lessons from IMPERIAL RCT (Eluvia DES vs. Zilver PTX)
8. 10:47 - 10:57
  
  Future trials with drug eluting technologies
9. 10:57 - 11:00
  
  Close and key take aways
Wednesday, January 29th: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: Approaches for fem-pop complex disease: What is the best option? Experts share treatment decisions and their cases

supported with an educational grant from Gore & Associates

Moderator:

Peter Soukas

Panel:

Michel Reijnen, Markus Steinbauer, Jorge Fernández Noya, Jose Antonio del Castro
1. 11:00 - 11:10
  
  The physician algorithm for treatment of fem-pop occlusive disease
2. 11:10 - 11:25
  
  Live case transmission from Paris
3. 11:25 - 11:35
  
  Treatment choice in complex SFA lesions
4. 11:35 - 11:45
  
  Endovascular first: When this is the appropriate choice?
5. 11:45 - 11:55
  
  GORE® VIABAHN® endoprosthesis in complex SFA lesions
6. 11:55 - 12:05
  
  Value of covered stents in fem-pop disease
7. 12:05 - 12:20
  
  Recorded case presentation
8. 12:20 - 12:30
  
  Discussion and conclusion
Wednesday, January 29th: 12:35 - 13:25, Room 1 - Main Arena 1

Lunch symposium: The latest in clinically proven technologies to treat complex PAD and venous diseases

sponsored by BD

Moderator:

Eric Ducasse

Panel:

Miguel Montero-Baker, Patrick Geraghty
1. 12:35 - 12:41
  
  How low pressure inflation with scoring technologies better preserves the vessel and increases revascularisation success
2. 12:41 - 12:47
  
  The UltraScore™ Scoring Ballon: Update of a multi-center registry
3. 12:47 - 12:53
  
  Update on the Lutonix® Drug Coated Balloon IDE trial with below-the-knee disease
4. 12:53 - 12:59
  
  FIRST TIME DATA RELEASE: The IDE below-the-knee Japan cohort
5. 12:59 - 13:05
  
  What we know about the paclitaxel-related mortality in femoro-popliteal arteries, and how it impacts my practice
6. 13:05 - 13:11
  
  Lutonix™ Drug Coated Balloon clinical program overview and published independent safety analysis results
7. 13:11 - 13:19
  
  Panel discussion
8. 13:19 - 13:25
  
  VENOVO® Arnsberg registry 24-month results
Wednesday, January 29th: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Redefining treatment strategy with new generation Sirolimus coated balloon for peripheral vascular disease with nanolute technology

supported with an educational grant from Concept Medical

Moderator:

Sahil Parikh

Panel:

Thomas Zeller, Dierk Scheinert, Jos van den Berg, Sameer Dani
1. 13:30 - 13:36
  
  The role of Sirolimus coated balloon in peripheral vascular disease
2. 13:36 - 13:42
  
  The Magic Touch – PTA Sirolimus coated balloon – insights from pre-clinical evaluation
3. 13:42 - 13:51
  
  XTOSI: MagicTouch sirolimus coated balloon for PAD and FUTURE SFA/FUTURE BTK randomised controlled trials
4. 13:51 - 14:11
  
  Live case transmission from Jena
5. 14:11 - 14:16
  
  Discussion on case
6. 14:16 - 14:36
  
  Live case transmission from Leipzig
7. 14:36 - 14:41
  
  Discussion on case
8. 14:41 - 14:48
  
  Outcomes of Sirolimus coated angioplasty balloon in the treatment of dysfunctional AVF and AVG
9. 14:48 - 14:53
  
  SIRONA – head to head comparison of Sirolimus vs. Paclitaxel drug eluting balloon for femoral popliteal artery
10. 14:53 - 15:00
  
  Discussion and conclusion
Wednesday, January 29th: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: Atherectomy as adjunctive or definitive therapy: What’s the data and what are the techniques?

Moderator:

John Rundback, Peter Schneider

Panel:

Daniela Branzan, Steven Kum, Theodosios Bisdas, Lawrence Garcia
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Carreer Award 2020 – Steven Kum and Parag Patel
2. 15:05 - 15:30
  
  Live case transmission from Kingsport
3. 15:30 - 15:38
  
  Indications and lesion selection for femoral-popliteal atherectomy
4. 15:38 - 15:46
  
  Tools, techniques, and tips for safe and successful atherectomy below-the-knee
5. 15:46 - 15:54
  
  Atherectomy and anti-restenotic therapy: What do we know so far and what are the likely next developments?
6. 15:54 - 16:02
  
  Complications of atherectomy and how to manage them
7. 16:02 - 16:27
  
  Live case transmission from Kingsport
8. 16:27 - 16:30
  
  Discussion and conclusion
Wednesday, January 29th: 16:30 - 18:00, Room 1 - Main Arena 1

Advanced techniques for complex femoropopliteal lesions

Moderator:

Thomas Zeller, George Adams

Panel:

Kazushi Urasawa, Brian DeRubertis, Peter Soukas, Torsten Fuß, Martin Werner, Lawrence Garcia
1. 16:30 - 16:35
  
  When, where, and how: An update on the support catheters
2. 16:35 - 16:41
  
  Step-by-step approach in CTOs and the need for retrograde approaches
3. 16:41 - 17:01
  
  Live case transmission from Leipzig
4. 17:01 - 17:06
  
  FIRST TIME DATA RELEASE: Advancing laser therapy: Different setting for different lesions
5. 17:06 - 17:11
  
  Benefit of lesion preparation with a rotational atherectomy device – mid-term outcomes
6. 17:11 - 17:16
  
  The future of scoring PTA & update of a multi-center registry ATK/BTK
7. 17:16 - 17:21
  
  FIRST TIME DATA RELEASE: IN.PACT global study 150mm cohort: Outcomes through 3 years
8. 17:21 - 17:26
  
  FIRST TIME DATA RELEASE: Drug-coated balloon outcomes in the femoropopliteal by vessel size
9. 17:26 - 17:46
  
  Live case transmission from Kingsport
10. 17:46 - 17:51
  
  Vessel preparation in calcified lesions: Which method for which lesion?
11. 17:51 - 18:00
  
  Discussion and conclusion
Thursday, January 30th: 8:00 - 9:30, Room 1 - Main Arena 1

The last frontiers: Extreme BTK interventions for limb salvage in CLI

Moderator:

Roberto Ferraresi, Steven Kum

Panel:

Dai-Do Do, Jihad Mustapha, Hiroyoshi Yokoi, Michael Edmonds, Francesco Liistro, Jim A. Reekers
1. 08:00 - 08:20
  
  Live case transmission from Abano Terme
2. 08:20 - 08:26
  
  Peripheral vascular morbidity and its treatment in diabetic patients with renal failure
3. 08:26 - 08:32
  
  How to guide your intervention with perfusion angiography
4. 08:32 - 08:38
  
  Advantages of intra-vascular imaging in BTK procedures
5. 08:38 - 08:43
  
  Drug-coated balloon angioplasty of infrapopliteal lesions in patients with critical limb ischaemia: 1-year results of the APOLLO trial
6. 08:43 - 08:49
  
  When is below-the-ankle angioplasty indicated?
7. 08:49 - 09:09
  
  Live case transmission from Leipzig
8. 09:09 - 09:14
  
  5-year results from the ABSORB BTK study: Bioresorbable scaffolds for the treatment of tibial artery stenosis
9. 09:14 - 09:19
  
  Latest experience with the 3F Microstent in complex BTK procedures
10. 09:19 - 09:30
  
  Discussion and conclusion
Thursday, January 30th: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Rotarex®S in ISR and bypass occlusion: Are they still only a niche indication?

supported with an educational grant from Straub Medical

Moderator:

Romaric Loffroy

Panel:

Bruno Freitas, Bruno Migliara, Christos Rammos
1. 09:30 - 09:40
  
  Rotarex®S for in-stent stenosis/occlusion: A French multicentre experience with 128 patients
2. 09:40 - 10:05
  
  Live case transmission from Leipzig
3. 10:05 - 10:15
  
  Rotarex®S for in-stent restenosis/occlusion: The Leipzig experience with more than 300 patients
4. 10:15 - 10:40
  
  Live case transmission from Leipzig
5. 10:40 - 10:50
  
  Clinical and cost effectiveness of treating bypass occlusion with Rotarex®S vs. surgery
6. 10:50 - 11:00
  
  SAVioR trial: Acute improvement of vascular function following debulking atherectomy with Rotarex®S
Thursday, January 30th: 11:00 - 12:30, Room 1 - Main Arena 1

Innovating dialysis access: Latest data and developments in creation, maintenance, and program implementation

sponsored by BD

Moderator:

Dierk Scheinert

Panel:

Nicholas Inston, Panagiotis Kitrou, Eric Ducasse, Tobias Steinke, Ounali Jaffer
1. 11:00 - 11:07
  
  The WavelinQ EndoAVF™ system: Past, present, future
2. 11:07 - 11:17
  
  Recorded case presentation: Procedure with the EndoAVF 4F™ system
3. 11:17 - 11:22
  
  The 1st French experience with the WavelinQ EndoAVF 4F™ system
4. 11:22 - 11:27
  
  EndoAVF secondary interventions
5. 11:27 - 11:37
  
  Panel discussion
6. 11:37 - 11:44
  
  The Covera™ Vascular Covered stent in fistula: the AVEVA & AVENEW studies
7. 11:44 - 11:54
  
  Recorded case presentations with Covera™ Vascular Covered stent
8. 11:54 - 12:04
  
  Panel discussion
9. 12:04 - 12:09
  
  DCB in central venous stenosis. A multicenter retrospective study
10. 12:09 - 12:15
  
  An overview of the Lutonix® Drug Coated Balloons clinical program and patient population characteristics
11. 12:15 - 12:20
  
  Use of drug-coated balloons in dysfunctional arteriovenous dialysis access treatment: The effect of consecutive treatments on lesion patency
12. 12:20 - 12:30
  
  Panel discussion
Thursday, January 30th: 12:30 - 13:30, Room 1 - Main Arena 1

Focus session: Percutaneous bypass technique for challenging femoropopliteal occlusions

Moderator:

Peter Schneider

Panel:

Dierk Scheinert, Kenneth Ouriel, Sean Lyden
1. 12:30 - 12:38
  
  Using the vein as a DETOUR to long, complex, CTOs
2. 12:38 - 12:58
  
  Live case transmission from Leipzig
3. 12:58 - 13:06
  
  Patient selection for the PQ Bypass DETOUR procedure
4. 13:06 - 13:30
  
  Discussion and conclusion
Thursday, January 30th: 13:30 - 15:00, Room 1 - Main Arena 1

Pioneering techniques for “no-option” CLTI patients – deep venous arterialization

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Roberto Ferraresi, Giacomo Clerici, Michiel Schreve
1. 13:30 - 13:36
  
  Promise and limitations of below-the-ankle revascularisation and pedal loop technique
2. 13:36 - 13:42
  
  The “no-option” CLTI population and prevalence of Small Artery disease
3. 13:42 - 13:48
  
  Surgical, hybrid, and percutaneous DVA – overview of techniques and limitations
4. 13:48 - 13:54
  
  LimFlow PROMISE I study results – the first prospective multi-center trial on DVA
5. 13:54 - 14:00
  
  Ultrasound guided distal AV fistula creations for segmental foot arterialization
6. 14:00 - 14:06
  
  DVA pathophysiology and mechanism of action
7. 14:06 - 14:12
  
  Post-DVA care in a multidisciplinary setting
8. 14:12 - 14:32
  
  Live case transmission from Leipzig
9. 14:32 - 15:00
  
  Discussion and conclusion
Thursday, January 30th: 15:00 - 18:00, Room 1 - Main Arena 1

The last frontiers: Remaining challenges, ongoing controversies, and unmet clinical needs

Moderator:

Jos van den Berg, Prakash Krishnan

Panel:

Torsten Fuß, Thomas Zeller, Hiroshi Ando, Michel Bosiers
1. FOCUS ON ULTRA-LONG LESIONS
2. 15:00 - 15:05
  
  The SUPER B RCT shows VIABAHN® endografts perform as well as open surgical fempop bypass grafts for 2 years
3. 15:05 - 15:10
  
  GORE® VIABAHN® endoprosthesis demonstrates powerful patency in 20+ cm SFA lesions
4. 15:10 - 15:35
  
  Live case transmission from Leipzig
5. 15:35 - 15:40
  
  The ZILVERPASS study: A randomized study comparing ZILVER PTX stenting with BYPASS in femoropopliteal lesions (final 24-month results)
6. FOCUS ON ADVANCED RECANALIZATION TECHNIQUES FOR “NO STENT ZONES”
7. 15:40 - 15:45
  
  Vessel preparation options when stenting is not an option in the popliteal artery
8. 15:45 - 15:50
  
  Utility of the orbital atherectomy system (CSI) in the treatment of no-stenting zones involving isolated lesions of the popliteal artery
9. 15:50 - 15:55
  
  Intravascular lithoplasty in calcified common femoral arteries
10. 15:55 - 16:20
  
  Live case transmission from Münster
11. FIRST CHOICE TREATMENT OF PAOD IN THE COMMON FEMORAL ARTERY
12. 16:20 - 16:25
  
  Pro surgery
13. 16:25 - 16:30
  
  Pro intervention
14. FOCUS ON SEVERE CALCIFIED OCCLUSIONS
15. 16:30 - 16:35
  
  Risk assessment of local lysis therapy in critical limb ischemia: who benefits, who does not?
16. 16:35 - 16:40
  
  My choice of atherectomy system in sever calcification
17. 16:40 - 16:45
  
  Use of Intravascular Lithotripsy in aorto-iliac occlusive disease
18. 16:45 - 16:50
  
  Crack-and-pave techniques: technical tips and follow-up data
19. 16:50 - 17:15
  
  Live case transmission from Leipzig
20. FOCUS ON THROMBUS CONTAINING LESIONS AND IN-STENT-RESTENOSIS
21. 17:15 - 17:20
  
  Treatment approaches for acute limb ischemia
22. 17:20 - 17:25
  
  Aspiration thrombectomy for acute limb ischemia. Is the era of Fogarty balloon over?
23. 17:25 - 17:50
  
  Live case transmission from Abano Terme
24. 17:50 - 17:55
  
  How to treat in-stent-restenosis in the femoropopliteal tract? What does the literature tells us?
25. 17:55 - 18:00
  
  Step by step approach for endovascular salvage of occluded fem-pop bypass
Friday, January 31st: 9:00 - 13:00, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting

Moderator:

Giovanni Torsello

Panel:

Martin Malina, Reza Ghotbi, Frank Vermassen, Dittmar Böckler, Armando Lobato

live from Münster:

Martin Austermann

live from Leipzig:

Andrej Schmidt
1. Join us for brunch, served from 08:45am until 11:00am
2. Endovascular management of traumatic aortic injuries: Challenges and solution
3. Successful treatment of post-traumatic arch pseudoaneurysm with fenestrated custom-made TEVAR
4. Endovascular treatment of aortic injury following thoracic spinal surgery: Case report and literature review
5. A new era for CO2 imaging just started
6. Role of cone beam CT in the treatment of ruptured AAA – are we ready to go?
7. Emergency intervention for retrograde Type A acute aortic dissection with PETTICOAT technique
8. Infected TEVAR, FEVAR, and BEVAR – open surgery reloaded

Room 2 - Main Arena 2

21 events

Tuesday, January 28th: 8:00 - 9:30, Room 2 - Main Arena 2

Acute deep vein thrombosis and post-thrombotic syndrome

Moderator:

Rick de Graaf

Panel:

Houman Jalaie, Oliver Schlager, Christian Erbel, Tim Sebastian
1. 08:00 - 08:10
  
  Efficacy and safety of novel mechanical thrombectomy systems for iliofemoral DVT
2. 08:10 - 08:20
  
  CAVA trial: why catheter interventions will remain the CAVALry of DVT treatment
3. 08:20 - 08:30
  
  Update on the ARIVA trial: Aspirin plus Rivaroxaban vs. Rivaroxaban alone for the prevention of stent thrombosis in PTS patients
4. 08:30 - 08:40
  
  The TOPOS study: Early outcomes of a hybrid oblique nitinol stent for PTS patients with common iliac vein compression
5. 08:40 - 08:50
  
  Validation of duplex sonography for the detection of venous stent stenosis – a case control study
6. 08:50 - 09:10
  
  Live case transmission from Zurich
7. 09:10 - 09:30
  
  Live case transmission from Galway
Tuesday, January 28th: 9:30 - 11:00, Room 2 - Main Arena 2

Iliac artery pathologies: Guidelines, treatment algorithms, and gaps

partially supported with an educational grant from Gore & Associates

Moderator:

Giovanni Torsello

Panel:

Alexander Maßmann, Jan Heyligers, Jorge Fernández Noya, Michel Reijnen, Maria Antonella Ruffino, Hans Krankenberg
1. 09:30 - 09:36
  
  IVUS for aorto-iliac disease: Is contrast media application and high energy radiation redundant?
2. 09:36 - 09:44
  
  Treatment approach for iliac occlusive disease: What is the best option? Experience and data
3. 09:44 - 10:04
  
  Live case transmission from Leipzig
4. 10:04 - 10:12
  
  Iliac branch device indication in consideration of guidelines and clinical data
5. 10:12 - 10:20
  
  Case based discussion: Device selection for a successful preservation
6. 10:20 - 10:26
  
  Options and optimal solutions for bridging stentin in renal artery
7. 10:26 - 10:32
  
  Dealing with emergencies in very complex cases: Why I always have enough covered stents on stock
8. 10:32 - 10:38
  
  Midterm outcome of CERAB and how to optimize results
9. 10:38 - 11:00
  
  Discussion and conclusion
Tuesday, January 28th: 11:00 - 12:30, Room 2 - Main Arena 2

Venous stent placement for post-thrombotic syndrome

Moderator:

Houman Jalaie, Stephen Black

Panel:

Rick de Graaf, Tim Sebastian, Olivier Hartung
1. 11:00 - 11:20
  
  Live case transmission from Galway
2. 11:20 - 11:40
  
  Live case transmission from Zurich
3. 11:40 - 11:48
  
  VENOVO® venous stent – 24-month update on the Vernacular trial
4. 11:48 - 11:56
  
  Analysis of venous intimal reaction after stent implantation: Does stent porosity matter?
5. 11:56 - 12:04
  
  IVUS for guiding endovascular therapy in deep veins
6. 12:04 - 12:12
  
  Dedicated woven nitinol stent for the common femoral vein: Arnsberg–Zurich experience
7. 12:12 - 12:20
  
  24-month patency rates and clinical results of the SINUS OBLIQUUS® venous stent: Data from the Arnsberg venous registry
8. 12:20 - 12:30
  
  Discussion and conclusion
Tuesday, January 28th: 12:30 - 13:25, Room 2 - Main Arena 2

Lunch symposium: SELUTION SLR™: A breakthrough in drug-eluting balloon technology

supported with an educational grant from Medalliance

Moderator:

Peter Gaines, Marianne Brodmann

Panel:

Aloke Finn, Thomas Zeller, Ulrich Beschorner, Tjun Yip Tang
1. 12:30 - 12:40
  
  Welcome and introduction
2. 12:40 - 12:50
  
  Importance of sustained drug release in DEB: Insights into preclinical data for the SELUTION SLR™
3. 12:50 - 13:00
  
  Sustained Limus release translating into sustained clinical outcomes: SELUTION SFA™ – 2-year results
4. 13:00 - 13:10
  
  SELUTION SLR™ in clinical practice: Angio case examples
5. 13:10 - 13:20
  
  How low can you go? SELUTION SLR™ below-the-knee and in tibial arteries – first experience
6. 13:20 - 13:25
  
  Next steps and adjourn
Tuesday, January 28th: 13:30 - 15:00, Room 2 - Main Arena 2

2020 Vision for venous interventions: Where do we go from here?

supported with an educational grant from Boston Scientific

Moderator:

Marzia Lugli, Olivier Hartung

Panel:

Stephen Black, Michael Lichtenberg, Houman Jalaie
1. 13:30 - 13:33
  
  Introduction and learning objectives
2. 13:33 - 13:45
  
  Post thrombotic disease: The relevance of long term follow up
3. 13:45 - 13:55
  
  Pathway for the accelerated treatment of venous leg ulcers
4. 13:55 - 14:05
  
  The VICI VENOUS STENT: 24-month outcome data
5. 14:05 - 14:10
  
  Panel discussion
6. 14:10 - 14:30
  
  Pharmacomechanical CDT: The future of DVT treatment?
7. 14:30 - 14:37
  
  Classification guided outcomes in chronic venous obstruction
8. 14:37 - 15:00
  
  A case based panel discussion
Tuesday, January 28th: 15:00 - 16:30, Room 2 - Main Arena 2

New concepts for AV-shunt revascularisation and central vein stenoses

Moderator:

Robert Lookstein, Andrew Holden

Panel:

Bart Dolmatch, Panagiotis Kitrou, Arne Schwindt, Daniela Branzan, Masahiko Fujihara
1. 15:00 - 15:06
  
  Innovative new device for fistula maturation in the management of dialysis access
2. 15:06 - 15:11
  
  FIRST TIME DATA RELEASE: AV is now endovascular – initial multi-center experience results of the WavelinQ
3. 15:11 - 15:16
  
  FIRST TIME DATA RELEASE: IN.PACT AV access study: 12 month primary outcomes
4. 15:16 - 15:21
  
  FIRST TIME DATA RELEASE: Drug-coated balloons in AV access: Budget impact model based on the IN.PACT AV access trial – US and German health system perspectives
5. 15:21 - 15:31
  
  Recorded live case using the IN.PACT AV access drug-coated balloon
6. 15:31 - 15:37
  
  How I use drug-coated balloons for AV access maintenance
7. 15:37 - 16:02
  
  Live case transmission from Galway
8. 16:02 - 16:07
  
  FIRST TIME DATA RELEASE: DCB for the treatment of symptomatic central venous stenosis. Results from a retrospective multicenter analysis
9. 16:07 - 16:13
  
  Value of stent-graft placement in hemodialysis patients with dysfunctional arteriovenous fistulas and grafts
10. 16:13 - 16:19
  
  Value of stent graft placement to treat cepahlic arch stenosis in hemodialysis patients
11. 16:19 - 16:24
  
  FIRST TIME DATA RELEASE: COVERA™ – 12-month update on AVeNEW trial for outflow stenosis in AV fistula circuits
12. 16:24 - 16:29
  
  FIRST TIME DATA RELEASE: COVERA™ – 24-month update on AVeVA study for treatment of venous anastomotic lesions in AV grafts
13. 16:29 - 16:30
  
  Discussion and conclusion
Tuesday, January 28th: 16:30 - 18:00, Room 2 - Main Arena 2

Scrub-in with the experts: Endovascular therapy of varicocele and the pelvic congestion syndrome

Moderator:

Olivier Hartung, Tim Sebastian

Panel:

Rick de Graaf, Marcus Treitl, Tobias Hirsch

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan
1. Flash presentation: Outcomes of endovascular treatment of PCS
2. Flash presentation: Varicocele and PCS – one and the same? Learning from cases
3. Flash presentation: Pelvic congestion syndrome: Underdiagnosed, misdiagnosed, and undertreated… What IVUS may show you
Wednesday, January 29th: 8:00 - 9:00, Room 2 - Main Arena 2

Endovascular repair of iliac artery aneurysms – current techniques and results

Moderator:

Armando Lobato, Frank Vermassen

Panel:

Spiridon Botsios, Sven Seifert, Reza Ghotbi
1. 08:00 - 08:06
  
  Unilateral and bilateral primary and secondary iliac aneurysms – endovascular treatment first!
2. 08:06 - 08:26
  
  Live case transmission from Münster
3. 08:26 - 08:32
  
  Comparison and results of endovascular repair techniques in elective bilateral aortoiliac aneurysms
4. 08:32 - 08:38
  
  Iliac branching and long-term value: How effective is preservation in a single center experience
5. 08:38 - 08:44
  
  Long-term experience and lessons learned with the COOK IBD
6. 08:44 - 08:52
  
  E-liac or Zenith® iliac side branch? A comparison from one center of 50 patients each
7. 08:52 - 09:00
  
  Discussion and conclusion
Wednesday, January 29th: 9:00 - 9:45, Room 2 - Main Arena 2

Innovations for daily practice: Advanced settings for hybrid ORs and new imaging modalities

Moderator:

Marc van Sambeek, Frans Moll

Panel:

Tilo Kölbel, Ramon Varcoe, Eric Ducasse, Alexander Gangl
1. 09:00 - 09:06
  
  Fiber Optic Real Shape (FORS) technology – 3D device guidance in practice
2. 09:06 - 09:12
  
  How to use MRI imaging for planning and fusion of a complex F/BEVAR procedure
3. 09:12 - 09:18
  
  Workflow & ergonomics improvements in the hybrid OR
4. 09:18 - 09:24
  
  CO2 angiography for EVAR treatment. Tips and tricks
5. 09:24 - 09:30
  
  Initial experience with the TrackCath system in endovascular repair of aortic aneurysms
6. 09:30 - 09:36
  
  Mechanical characterisation of abdominal aortic aneurysm, using 4D ultrasound
7. 09:36 - 09:42
  
  The EndoStore APP: Efficient & reliable logistics at your fingertips
8. 09:42 - 09:45
  
  Discussion and conclusion
Wednesday, January 29th: 9:45 - 11:00, Room 2 - Main Arena 2

Current status of EVAR for infrarenal aortic aneurysms: Latest guidelines and new data

Moderator:

Vicente Riambau, Roger Greenhalgh

Panel:

Gianluca Faggioli, Spiridon Botsios, Germano Melissano, Hendrik Verhagen, Martin Malina
1. 09:45 - 09:51
  
  Impact of centralization on abdominal aortic aneurysm repair outcomes: Early experience in public health system
2. 09:51 - 09:57
  
  The choice of EVAR vs. OSR: Extreme local variation suggests the impact of political rather than medical factors!
3. 09:57 - 10:03
  
  Gender differences in EVAR/FEVAR/BEVAR
4. 10:03 - 10:23
  
  Recorded case presentation: EVAR with Altura stentgraft
5. 10:23 - 10:29
  
  Proven durability and staying inside the IFU for challenging aortic necks
6. 10:29 - 10:35
  
  ENCORE study update: Durability through Polymer sealing using the Ovation AAA stent graft system
7. 10:35 - 10:41
  
  Long-term performance of endovascular repair of abdominal aortic aneurysms with the TREO graft
8. 10:41 - 10:47
  
  Clinical experience with Lifetech scientific abdominal stent graft
9. 10:47 - 10:53
  
  Making EVAR safer in the long term: Using ultrasound to measure aortic sac diameter annually at home
10. 10:53 - 10:59
  
  The NICE guidelines: Nice or not so nice?
11. 10:59 - 11:00
  
  Discussion and conclusion
Wednesday, January 29th: 11:00 - 12:30, Room 2 - Main Arena 2

COOK off the shelf solutions for thoracic and thoracoabdominal aneurysm – updates and live case

supported with an educational grant from COOK Medical

Moderator:

Tilo Kölbel

Panel:

Nikolaos Tsilimparis, Germano Melissano, Michel Bosiers
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:13
  
  Zenith® Alpha TAA: The importance of precision, optimal sealing, and active fixation when treating thoracic aneurysm
3. 11:13 - 11:21
  
  Long-term outcomes using Alpha Thoracic: How to achieve durability
4. 11:21 - 11:46
  
  Live case transmission from Münster
5. 11:46 - 11:54
  
  Early outcomes from Post Market Observational study on Zenith® t-Branch® endograft
6. 11:54 - 12:30
  
  Discussion and conclusion
Wednesday, January 29th: 12:35 - 13:25, Room 2 - Main Arena 2

Lunch symposium: The importance of proven balloon expandable covered stents in the current endovascular era

supported with an educational grant from Getinge

Moderator:

Jean-Paul de Vries

Panel:

Patrice Mwipatayi, Bram Fioole, Sebastian Carpenter
1. 12:35 - 12:50
  
  When are covered stents the best treatment for aorto-iliac occlusive disease: Which is the best stent-graft for this: What are the long-term results?
2. 12:50 - 13:05
  
  Relevance and current update of the DISCOVER Dutch iliac stent trial
3. 13:05 - 13:20
  
  Case presentations: Using proven covered stents to treat complex aorto-iliac occlusive disease
Wednesday, January 29th: 13:30 - 15:00, Room 2 - Main Arena 2

Challenges in endovascular aortic repair: Treatment of juxtarenal aneurysms

Moderator:

Giovanni Torsello, Eric Verhoeven

Panel:

Konstantinos Donas, Ralf Kolvenbach, Michel Reijnen, Markus Steinbauer, Ramon Varcoe
1. 13:30 - 13:36
  
  Preliminary data from the EAGLE registry
2. 13:36 - 13:42
  
  Contemporary options for treating juxtarenal aneurysm when infrarenal sealing is not enough
3. 13:42 - 13:48
  
  Mid-term results from ANCHOR and how these clinical insights affect my clinical practice
4. 13:48 - 13:54
  
  Why 3xFEVAR has replaced 2xFEVAR and FEVAR better than CHEVAR
5. 13:54 - 14:04
  
  Recorded case presentation: EVAR with Ovation stentgraft and Cydar intelligent navigation system
6. 14:04 - 14:10
  
  Useful combinations of aortic endoprosthetic material of different companies in complex situations
7. 14:10 - 14:16
  
  Is ChEVAS the answer to complex AAA treatment? The future of Nellix in 2020
8. 14:16 - 14:36
  
  Live case transmission from Paris
9. 14:36 - 14:42
  
  Lessons learned 5 years after the PERICLES registry publication: A position statement about the current role of chimney endografting
10. 14:42 - 14:48
  
  Long term results of chimney graft branches in juxtarenal aneurysms
11. 14:48 - 14:54
  
  Freedom to fenestrate: How the Anaconda platform has impacted my practice
12. 14:54 - 15:00
  
  Cost effectiveness analysis of FEVAR vs. CHEVAR in juxtarenal aortic aneurysms: A new insight in the old debate
Wednesday, January 29th: 15:00 - 16:30, Room 2 - Main Arena 2

CX@LINC: Towards aortic advances

Moderator:

Roger Greenhalgh

Panel:

Tilo Kölbel, Frans Moll
1. 15:00 - 15:10
  
  Effects of long thoracic stent grafts on the pathophysiology of the heart
2. 15:10 - 15:20
  
  Audience participation
3. 15:20 - 15:30
  
  Access-techniques to simplify fenestrated and branched EVAR: Upper extremity access is not needed any longer
4. CX EDITED LIVE CASE: FULL TRANSFEMORAL BRANCHED EVAR FOR THORACOABDOMINAL AORTIC ANEURYSMS
5. 15:30 - 15:40
  
  Recorded case presentation
6. 15:40 - 15:50
  
  Audience participation
7. 15:50 - 16:00
  
  Modern imaging systems will revolutionize EVAR techniques
8. 16:00 - 16:10
  
  Audience participation
9. CX EDITED LIVE CASE: FENESTRATED ARCH REPAIR IN CHRONIC TYPE B AORTIC DISSECTION
10. 16:10 - 16:20
  
  Recorded case presentation
11. 16:20 - 16:30
  
  Audience participation
Wednesday, January 29th: 16:30 - 18:00, Room 2 - Main Arena 2

Re-do procedures after EVAR and management of endoleaks

Moderator:

Giovanni Torsello, Eric Ducasse

Panel:

Giovanni Federico Torsello, Jean-Paul de Vries, Michel Bosiers, Michel Reijnen
1. 16:30 - 16:36
  
  Endoleak follow-up and true sac evolution
2. 16:36 - 16:42
  
  Direct percutaneous sac puncture: An easy way to solve post-EVAR Type II endoleaks
3. 16:42 - 16:48
  
  Direct puncture technique using Onyx 34L for endoleak management
4. 16:48 - 16:54
  
  Intentional aorto-caval fistula: An unexploited opportunity to treat Type II endoleaks and prevent paraplegia?
5. 16:54 - 17:00
  
  Role of IMA in Type II endoleak after endovascular treatment
6. 17:00 - 17:06
  
  Value of preliminary selective lumbar and inferior mesenteric artery embolization to prevent Type II endoleaks after EVAR
7. 17:06 - 17:26
  
  Live case transmission from Münster
8. 17:26 - 17:32
  
  Occlusions in EVAR: What is the impact on early outcomes, quality of life, and cost efficiency?
9. 17:32 - 17:38
  
  Determination of endograft apposition at the 30-days post-EVAR CT scan can predict later failure
10. 17:38 - 17:44
  
  Rare complication of standard EVAR treated with rare device
11. 17:44 - 17:50
  
  Endorepair of migrated endografts using the Altura endograft system: When and how to do it
12. 17:50 - 17:56
  
  Trouble shooting and bail-out in FEVAR and BEVAR
13. 17:56 - 18:00
  
  Discussion and conclusion
Thursday, January 30th: 8:00 - 9:30, Room 2 - Main Arena 2

New insights and current techniques for thoracic endovascular aortic repair

Moderator:

Vicente Riambau, Giovanni Torsello

Panel:

Tilo Kölbel, Marc van Sambeek, Eric Ducasse, Martin Malina, Ayman Al-Sibaie, Matteo Orrico
1. 08:00 - 08:05
  
  Valiant Navion: What have we learned about this next generation TEVAR device: 1-year results from the global clinical trial
2. 08:05 - 08:10
  
  Addressing unmet clinical needs with a new generation TEVAR device: Practical application of the Valiant Navion
3. 08:10 - 08:15
  
  The Fustar steerable sheath in my daily practice: When and how?
4. 08:15 - 08:20
  
  Insights on TEVAR from the SURPASS registry
5. 08:20 - 08:50
  
  Live case transmission from Münster
6. 08:50 - 08:55
  
  Incidence and predictors of early and mid-term neurological complications following thoracic endovascular repair
7. 08:55 - 09:05
  
  Recorded case presentation: Relay proximal scallop?
8. 09:05 - 09:10
  
  Stroke in TEVAR: how to minimize cerebral damage?
9. 09:10 - 09:15
  
  Aortyx patch: an innovative repair approach for focal aortic defects
10. 09:15 - 09:20
  
  BEVAR by femoral approach with a steerable sheath
11. 09:20 - 09:30
  
  Discussion and conclusion
Thursday, January 30th: 9:30 - 11:00, Room 2 - Main Arena 2

Symposium: Achieving durable outcomes in endovascular aortic repair: Lessons learned on the benefits of the GORE® ACTIVE CONTROL system

supported with an educational grant from Gore & Associates

Moderator:

Santi Trimarchi

Panel:

Dittmar Böckler, Hendrik Verhagen, Marc van Sambeek, Nilo Mosquera, Giovanni Pratesi
1. 09:30 - 09:35
  
  Introduction
2. 09:35 - 09:50
  
  Active control in TEVAR: When is the use of angulation control beneficial for achieving optimal outcomes?
3. 09:50 - 10:10
  
  Recorded case presentation: Thoracic case with TAG Conformable with active control performed by
4. 10:10 - 10:25
  
  Active control in EVAR: Orthogonal placement and 360 seal using the angulation control
5. 10:25 - 10:45
  
  Recorded case presentation: Abdominal case with EXCC performed by
6. 10:45 - 11:00
  
  Value of conformability for the success of aortic endovascular repair in the short and long term
Thursday, January 30th: 11:00 - 12:30, Room 2 - Main Arena 2

Pioneering techniques for pathologies of the ascending aorta and the aortic arch

Moderator:

Tilo Kölbel, Roberto Chiesa

Panel:

Ralf Kolvenbach, Vicente Riambau, Andrew Holden, Matteo Orrico, Xin Jia
1. 11:00 - 11:06
  
  Accuracy and alignment near and in the aortic arch
2. 11:06 - 11:12
  
  Safety and effectiveness of a proximal scallop endograft for deployment close to the supra-aortic trunks: Results of a prospective, multicenter clinical study
3. 11:12 - 11:18
  
  Endovascular treatment of aortic arch disease
4. 11:18 - 11:24
  
  The role of double layer PTFE grafts and in situ fenestration in complex aortic arch cases
5. 11:24 - 11:30
  
  Parallel grafts for aortic arch lesions; tips to make them work and when do they
6. 11:30 - 11:55
  
  Live case transmission from Paris
7. 11:55 - 12:01
  
  Aortic arch reconstruction with a newly-designed modular branched stent graft – a first in man study
8. 12:01 - 12:07
  
  Endovascular treatment of the ascending aorta – are there indications?
9. 12:07 - 12:13
  
  Endovascular treatment of true ascending aortic aneurysms: The last endovascular frontier?
10. 12:13 - 12:19
  
  Endospan Nexus for zone 1 disease of the aortic arch
11. 12:19 - 12:25
  
  Why and how to wrap the dilated ascending aorta: Indications, contraindications, technical tips, and results
12. 12:25 - 12:30
  
  Discussion and conclusion
Thursday, January 30th: 13:30 - 15:00, Room 2 - Main Arena 2

EVAR for aortic dissections, ruptured aneurysms, and aortic infections

Moderator:

Vicente Riambau, Tilo Kölbel

Panel:

Martin Malina, Sven Seifert, Dittmar Böckler, Matteo Orrico, Xin Jia
1. FOCUS ON AORTIC DISSECTION MANAGMENT
2. 13:30 - 13:36
  
  Results of early TEVAR in acute/subacute uncomplicated Type B dissection
3. 13:36 - 13:42
  
  Morphologic changes in dissected aortas after TEVAR: Remodeling aortas
4. 13:42 - 13:48
  
  Factors indicating complication for a still uncomplicated Type B dissection
5. 13:48 - 13:54
  
  How to take care of the false lumen in chronic aortic dissection
6. 13:54 - 14:00
  
  Indicators for distal stent-graft induced new entry (SINE) & controversial discussion and results
7. 14:00 - 14:06
  
  Conventional surgery for Type A aortic dissection: What’s new?
8. 14:06 - 14:32
  
  Live case transmission from Münster
9. FOCUS ON MANAGEMENT OF RUPTURED ANEURYSMS AND AORTIC INFECTIONS
10. 14:32 - 14:38
  
  Clinical experience for the treatment of PAU
11. 14:38 - 14:44
  
  Ruptured AAA – open and endo are complementary and required
12. 14:44 - 15:00
  
  Discussion and conclusion
Thursday, January 30th: 15:00 - 16:00, Room 2 - Main Arena 2

Symposium: Sac dynamics in EVAR: Why AAA sac regression matters

sponsored by Medtronic

Moderator:

Vicente Riambau, Jean-Paul de Vries

Panel:

Michel Reijnen, Hendrik Verhagen, Giovanni Pratesi
1. 15:00 - 15:02
  
  Introduction
2. 15:02 - 15:11
  
  Why sac regression matters; how our experience with Endurant informs our practice
3. 15:11 - 15:20
  
  How does Type II endoleaks and secondary interventions play a role in overall sac dynamics?
4. 15:20 - 15:29
  
  What role do EndoAnchors play in AAA sac dynamics?
5. 15:29 - 16:00
  
  Discussion and conclusion
Thursday, January 30th: 16:00 - 18:00, Room 2 - Main Arena 2

Latest techniques for endovascular repair of thoracoabdominal aneurysms and management of aortic ruptured or infected aneurysms

Moderator:

Eric Verhoeven, Michael Borger

Panel:

Tilo Kölbel, Roberto Chiesa, Daniela Branzan, Matteo Orrico, Xin Jia
1. 16:00 - 16:05
  
  When and how to treat patients with genetic aortic disorders by endovascular aortic techniques?
2. 16:05 - 16:10
  
  TAAA open repair: Updated results in the modern adjuncts era
3. 16:10 - 16:15
  
  Mortality/complications during waiting time for custom made grafts in more than 1,000 F&B patients
4. 16:15 - 16:40
  
  Live case transmission from Paris
5. 16:40 - 16:45
  
  3D aortic models for the urgent endovascular treatment of thoracoabdominal and juxtarenal aortic pathologies using physician modified stent-grafts
6. 16:45 - 16:50
  
  Parallel grafts is the best way to treat ruptured complex (T)AAAs
7. 16:50 - 17:00
  
  Recorded case presentation: Relay + 4-fenestration Anaconda case (edited)
8. 17:00 - 17:05
  
  Endovascular repair of thoracoabdominal aortic aneurysms with a novel integrated multi-branched stentgraft – a first in man study
9. 17:05 - 17:10
  
  A simplified technique for transfemoral access to antegrade branches in complex aortic repair
10. 17:10 - 17:15
  
  Mechanical and clinical bridging stent-graft stability
11. 17:15 - 17:20
  
  The usage of BX over SX covered stents to improve the clinical outcome in BEVAR
12. 17:20 - 17:25
  
  Overview of current strategies to prevent spinal cord ischemia during endovascular TAAA repair
13. 17:25 - 17:30
  
  Segmental artery coil embolization to prime the spinal cord collateral network before EVAR: Concept and early results
14. 17:30 - 17:55
  
  Live case transmission from Münster
15. 17:55 - 18:00
  
  Discussion and conclusion

Room 3 - Technical Forum

20 events

Tuesday, January 28th: 10:00 - 12:30, Room 3 - Technical Forum

Management of carotid artery disease: Current status, new developments, and future outlook

Moderator:

Horst Sievert, Piotr Odrowaz-Pieniazek

Panel:

Richard Bulbulia, Stefan Müller-Hülsbeck, Martin Storck
1. 10:00 - 10:06
  
  Is classical surgery for carotid disease still necessary in the future?
2. 10:06 - 10:12
  
  The ACST-2 trial – recruitment complete, what are the characteristics of our patients, operators, and interventions?
3. 10:12 - 10:48
  
  Live case transmission from Bergamo
4. 10:48 - 10:54
  
  FIRST TIME DATA RELEASE: Performance I trial: 6-month data from a trial using a novel carotid stent, post dilatation balloon and embolic protection device (Neuroguard) for the treatment of carotid stenoses
5. 10:54 - 11:00
  
  FIRST TIME DATA RELEASE: Latest data from the Roadsaver registry
6. 11:00 - 11:06
  
  Dual layer stents for treatment of symptomatic and asymptomatic carotid artery stenosis: 6-year data of a high-volume centre – Is re-occlusion an issue?
7. 11:06 - 11:12
  
  A radial access solution for embolic protection during carotid stenting
8. 11:12 - 11:18
  
  Proximal and distal embolic protection for carotid stenting
9. 11:18 - 11:24
  
  ROADSTER 2 trial results: TCAR is ready for prime time
10. 11:24 - 11:44
  
  Live case transmission from Berlin
11. 11:44 - 11:50
  
  Transcervical carotid stenting with flow reversal in high risk patients – clinical results and DWMRI findings
12. 11:50 - 11:56
  
  Evaluation of CEA techniques with a simulation tool
13. 11:56 - 12:02
  
  Does carotid intervention prevent dementia? Long term results from over 1,600 patients randomised to CEA or no procedure in ACST-1
14. 12:02 - 12:08
  
  Essential imaging for treatment of acute ischemic stroke
15. 12:08 - 12:14
  
  Acute stroke interventions in a cardiology department
16. 12:14 - 12:20
  
  Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
17. 12:20 - 12:26
  
  Management of vertebral artery dissection: The reconstructive and the deconstructive approach
18. 12:26 - 12:30
  
  Discussion and conclusion
Tuesday, January 28th: 13:30 - 14:15, Room 3 - Technical Forum

Scrub-in with the experts: Interventional techniques for complex femoropopliteal obstructions (part I)

Moderator:

Brian DeRubertis, Giancarlo Biamino

Panel:

Gunnar Tepe, Erwin Blessing, Klaus Amendt

live from Berlin:

Ralf Langhoff
1. Flash presentation: Final results and insights of the LOCOMOTIVE (full cohort)
2. Flash presentation: Learning from LOCOMOTIVE and CONSEQUENT: Spot stenting with DCB in high risk patients
3. Flash presentation: Case discussion: VascuFlex 2-LOC/3-LOC in long & complex fempop lesion
Tuesday, January 28th: 14:15 - 15:00, Room 3 - Technical Forum

Scrub-in with the experts: Interventional techniques for complex femoropopliteal obstructions (part II)

Moderator:

Brian DeRubertis, Giancarlo Biamino

Panel:

Gunnar Tepe, Erwin Blessing, Klaus Amendt

live from Leipzig:

Matthias Ulrich
1. Flash presentation: Current approaches for biomimetic implants
Tuesday, January 28th: 15:00 - 16:30, Room 3 - Technical Forum

Controversies in endovascular treatment in 2020 – Objective: Address and debate multiple approaches in treatment of carotid and femoropopliteal lesions

supported with an educational grant from Terumo

Panel:

Koen Deloose, Gunnar Tepe, Yann Gouëffic, Miltiadis Krokidis, Michael Lichtenberg, Ernst Weigang
1. CONTROVERSIES IN CAROTID TREATMENT
2. 15:00 - 15:07
  
  CEA: What else?
3. 15:07 - 15:14
  
  CAS: Time to revisit the guidelines?
4. 15:14 - 15:19
  
  Conclusion 1
5. 15:19 - 15:39
  
  Live case transmission from Bergamo
6. CONTROVERSIES IN FEM-POP TREATMENT
7. 15:39 - 15:46
  
  Drug-coated balloons: My life after the meta-analysis storm
8. 15:46 - 15:53
  
  Scaffolds are there to stay
9. 15:53 - 15:58
  
  Conclusion 2
10. 15:58 - 16:30
  
  Discussion and conclusion
Tuesday, January 28th: 16:30 - 18:00, Room 3 - Technical Forum

Scrub-in with the experts: Complex obstructions of the aortoiliac segement or supraortic branches

Moderator:

Jörn Balzer

Panel:

Patrice Mwipatayi, Spiridon Botsios

live from Leipzig:

Sven Bräunlich

live from Bergamo:

Fausto Castriota, Antonio Micari
1. Flash presentation: Management of severe TASC C-D aorto iliac disease
2. Flash presentation: Advantages of balloon expandable covered stents – challenges in aortic complex procedures
3. Flash presentation: Outcome of covered stent in the subclavian artery
4. Flash presentation: Carotid stenting – in stent restenosis and treatment modalities
Wednesday, January 29th: 8:00 - 9:30, Room 3 - Technical Forum

Focus session: Embolisation therapies liver and interventional oncology (part I)

Moderator:

Ulf Teichgräber, Thomas J. Vogl

Panel:

Alessandro Lunardi, Tim Ole Petersen, Bernhard Gebauer, Robert Lookstein
1. 08:00 - 08:08
  
  Beyond permanent particles: Rationale to use biodegradable particles for HCC
2. 08:08 - 08:33
  
  Live case transmission from Frankfurt
3. 08:33 - 08:41
  
  Pre-operative portal vein embolisation: Indications and patient selection
4. 08:41 - 08:49
  
  Venous embolisation before liver surgery: Technical aspects
5. 08:49 - 09:14
  
  Live case transmission from Jena
6. 09:14 - 09:22
  
  Percutaneous intrahepatic split by microwave ablation
Wednesday, January 29th: 9:30 - 11:00, Room 3 - Technical Forum

Focus session: AVM

Moderator:

Ulf Teichgräber, Walter Wohlgemuth

Panel:

Bernhard Gebauer, René Müller-Wille, Maximilian de Bucourt
1. 09:30 - 09:38
  
  Classification of vascular anomalies – recent update of the ISSVA classification
2. 09:38 - 09:59
  
  Recorded case presentation
3. 09:59 - 10:07
  
  Clinical and imaging diagnosis of vascular anomalies
4. 10:07 - 10:15
  
  Interventional therapy options – what and when
5. 10:15 - 10:23
  
  Embolisation and erectile dysfunction
6. 10:23 - 10:44
  
  Live case transmission from Frankfurt
7. 10:44 - 10:52
  
  Specifics of invasive therapy in a pediatric age group
8. 10:52 - 11:00
  
  Free evidence-based knowledge in the internet
Wednesday, January 29th: 11:00 - 12:30, Room 3 - Technical Forum

Focus session: Embolisation therapies liver and interventional oncology (part II)

Moderator:

Thomas J. Vogl

Panel:

Peter Huppert, Michael Moche, Amer Malouhi, Stefan Müller-Hülsbeck
1. 11:00 - 11:08
  
  Balloon TACE: How to do it – clinical evidence
2. 11:08 - 11:37
  
  Live case transmission from Jena
3. 11:37 - 11:45
  
  Update on the evidence of TACE
4. 11:45 - 12:14
  
  Live case transmission from Frankfurt
5. 12:14 - 12:22
  
  Hepatic infusion techniques in interventional oncology
6. 12:22 - 12:30
  
  The role of Antio-CT in interventional oncology
Wednesday, January 29th: 12:35 - 13:25, Room 3 - Technical Forum

Lunch symposium: Keep calm and NiTiDES: The first effective SFA Sirolimus eluting stent

supported with an educational grant from Alvimedica

Moderator:

Dierk Scheinert, Ralf Langhoff

Panel:

Stefan Müller-Hülsbeck, Konstantinos Katsanos, Andrea Kahlberg
1. 12:35 - 12:38
  
  Introduction and session objectives
2. 12:38 - 12:46
  
  Why, when, and where: The DES role in SFA treatment
3. 12:46 - 12:54
  
  Drugs on the stage: What we know and what we should know
4. 12:54 - 13:02
  
  NiTiDES: The innovative approach for SFA lesions
5. 13:02 - 13:10
  
  ILLUMINA study: 2-year results
6. 13:10 - 13:20
  
  Discussion
7. 13:20 - 13:25
  
  From theory to practice
Wednesday, January 29th: 13:30 - 15:00, Room 3 - Technical Forum

VIVA@LINC: Carotid revascularisation in 2020

Moderator:

Sean Lyden, Peter Schneider

Panel:

William Gray, Martin Werner, Sabine Steiner, Ravish Sachar

live from Kingsport:

Chris Metzger

live from Leipzig:

Andrej Schmidt
1. Flash presentation: Clinical trials in carotid disease: What is the state-of-the-art post-CREST?
2. Flash presentation: Latest data on TCAR
3. Flash presentation: Timing of carotid bifurcation repair after symptoms: How does it affect stroke risk?
4. Flash presentation: Managing restenosis after CAS or CEA
Wednesday, January 29th: 15:00 - 16:30, Room 3 - Technical Forum

Focus session: Embolisation therapies – interventional radiology (part III)

Moderator:

Ulf Teichgräber, Thomas J. Vogl

Panel:

Tobias Franiel, Boris Radeleff, Jörn Balzer, Konstantinos Katsanos, Marcus Treitl
1. 15:00 - 15:07
  
  PAE: Patient selection and indication
2. 15:07 - 15:27
  
  Live case transmission from Frankfurt
3. 15:27 - 15:34
  
  Cryotherapy
4. 15:34 - 15:41
  
  Bariatric embolization: Technique and clinical data
5. 15:41 - 15:48
  
  Embolization of rectal arteries in the treatment of hemorrhoidal disease
6. 15:48 - 16:09
  
  Live case transmission from Jena
7. 16:09 - 16:16
  
  Longterm results PAE
8. 16:16 - 16:23
  
  Hepatic venous outflow obstruction: Recanalisation techniques
9. 16:23 - 16:30
  
  Remote proctoring for advanced embolization techniques
Wednesday, January 29th: 16:30 - 18:00, Room 3 - Technical Forum

Miscellaneous topics: Renal, visceral interventions, and beyond

Moderator:

Peter Huppert, Robert Beasley

Panel:

Stefan Müller-Hülsbeck, Daniel Thomas, Robert Lookstein, Steffen Basche
1. 16:30 - 16:36
  
  Current methods of interventional hemorrhage management
2. 16:36 - 16:42
  
  The use of liquid embolics for hemorrhage management
3. 16:42 - 16:48
  
  Treatment of visceral aneurysms with detachable coils
4. 16:48 - 16:54
  
  Left gastric artery embolization for the treatment of obesity
5. 16:54 - 17:14
  
  Live case transmission from Jena
6. 17:14 - 17:20
  
  Portal vein recanalisation: Indications, techniques, and clinical results
7. 17:20 - 17:26
  
  The impact of controlled expansion TIPS: 1-year clinical results and real life experience
8. 17:26 - 17:32
  
  A treatment algorithm for acute mesenteric ischemia
9. 17:32 - 17:38
  
  Patency after stenting of the superior mesenteric artery
10. 17:38 - 17:44
  
  Is bilateral hypogastric artery occlusion safe?
11. 17:44 - 18:00
  
  Live case transmission from Leipzig
Thursday, January 30th: 8:00 - 9:00, Room 3 - Technical Forum

CLI and CTO summit – complex aortoiliac and femoral interventions

Moderator:

Lawrence Garcia, Patrice Mwipatayi

Panel:

Hans Krankenberg, Stanislaw Bartus

live from Leipzig:

Sven Bräunlich
1. Flash presentation: Role for EVUS and IVUS in complex CLI revascularisation
Thursday, January 30th: 9:00 - 10:00, Room 3 - Technical Forum

Step by step algorithmic approach to optimize patients outcomes

supported with an educational grant from Abbott Vascular

Moderator:

Lieven Maene

Panel:

Enrique Alejandre Lafont, Gianbattista Parlani, Ralf Langhoff
1. 09:00 - 09:05
  
  Opening
2. 09:05 - 09:15
  
  Supera in CFA
3. 09:15 - 09:25
  
  Supera for CTO – subintimal approach
4. 09:25 - 09:35
  
  Supera for treatment of long dissections
5. 09:35 - 09:45
  
  Supera in calcified lesions
6. 09:45 - 10:00
  
  Closing
Thursday, January 30th: 10:00 - 11:00, Room 3 - Technical Forum

CLI and CTO summit – complex femoral and BTK interventions

Moderator:

Ralf Langhoff, Antonio Micari

Panel:

A.R. Chandrashekar, Brian DeRubertis, Giancarlo Biamino

live from Abano Terme:

Marco Manzi
1. Flash presentation: Common femoral endovascular therapy: what we can learn from coronary intervention
2. Flash presentation: Bioresorbable technology for BTK arteries: Existing data and future trials
3. Flash presentation: Utility of TCPO2 in managing critical limb threatening ischemia
Thursday, January 30th: 11:00 - 12:30, Room 3 - Technical Forum

The VEITHsymposium session: The use of ultrasound to facilitate complex endovascular techniques, minimize radiation exposure, and limit contrast material

Moderator:

Enrico Ascher

Panel:

Natalie Marks, Steven Kum
1. 11:00 - 11:07
  
  Endovascular repair of popliteal artery aneurysms using duplex scan as the sole imaging technique: It is feasible, quick and more accurate than standard angiography
2. 11:07 - 11:14
  
  The value of SFA gray scale medium in predicting successful crossings in CTOs and popliteal artery volume flow as a predictor successful SFA stenting
3. 11:14 - 11:21
  
  The utility of transcutaneous ultrasound to determine procedural endpoints – The BIO REACT study concept
4. 11:21 - 11:28
  
  The use of ultrasound guidance for retrograde access
5. 11:28 - 11:35
  
  The value and limitations of transcutaneous ultrasound to guide challenging limb salvage procedures
6. 11:35 - 11:42
  
  Japanese experience with transcutaneous and intravascular ultrasound to guide peripheral interventions
7. 11:42 - 11:49
  
  What can we learn from transcutaneous ultrasound to facilitate very distal and crossing of challenging CTOs
8. 11:49 - 11:56
  
  Opportunities of real-time 3D ultrasound using XL14-3 for guiding intervention in vascular disease
9. 11:56 - 12:03
  
  Carotid stenting under duplex guidance: Is it possible? Is it safe?
10. 12:03 - 12:10
  
  Can lower extremity acute arterial occlusions be treated under duplex guidance alone? YES!
11. 12:10 - 12:30
  
  Discussion and conclusion
Thursday, January 30th: 12:30 - 13:30, Room 3 - Technical Forum

Lunch symposium: BioMimics 3D – The Swirling Flow® stent: nature’s alternative to drug elution

supported with an educational grant from Veryan

Moderator:

Peter Gaines

Panel:

Sebastian Carpenter, Jan Kröger, Michael Piorkowski, Michael Lichtenberg
1. 12:30 - 12:40
  
  The Paclitaxel controversy: Where we are now
2. 12:40 - 12:50
  
  Swirling Flow®: Nature’s alternative to drug elution
3. 12:50 - 13:00
  
  4D MRI evidence: Swirling Flow® is real
4. 13:00 - 13:10
  
  BioMimics3D® in my clinical pratice
5. 13:10 - 13:20
  
  BioMimics3D®: The latest clinical evidence from the MIMICS clinical programme
6. 13:20 - 13:30
  
  Discussion and conclusion
Thursday, January 30th: 13:30 - 15:00, Room 3 - Technical Forum

PAIRS@LINC – embolization: Techniques and indications

Moderator:

Ayman Al-Sibaie, Ulf Teichgräber

Panel:

Mohammad Altwalah, Mohamed Almoaiqel, Karim Abd El Tawab, Mohamed Aggour, Mohammad Badran
1. 13:30 - 13:38
  
  Hemoptysis: Endovascular management
2. 13:38 - 13:46
  
  Varicocele embolization
3. 13:46 - 13:54
  
  Fibroid embolization
4. 13:54 - 14:02
  
  Prostatic artery embolization: Experience from the Arab world
5. 14:02 - 14:10
  
  Non-fibroid embolization (adenomyosis, Fallopian tube embolization, and pelvic congestion syndrome in the Middle East)
6. 14:10 - 14:18
  
  Endovascular management of epistaxis and Iatrogenic traumas
7. 14:18 - 14:26
  
  Lymphatic embolization: Basic to advanced
8. 14:26 - 15:00
  
  Discussion and conclusion
Thursday, January 30th: 15:00 - 17:00, Room 3 - Technical Forum

Pioneering techniques for critical limb ischemia and “no-option” patients

Moderator:

Giancarlo Biamino

Panel:

Antonio Micari, Hiroyoshi Yokoi, Olaf Bakker

live from Abano Terme:

Marco Manzi

live from Leipzig:

Andrej Schmidt
1. Recorded case presentation: LimFlow procedure in end stage CLI
2. Flash presentation: Perfusion assessment in CLI – current technologies
3. Flash presentation: ByCross rotational artherectomy: technical aspects of a new device with a new philosophy
Friday, January 31st: 9:00 - 13:00, Room 3 - Technical Forum

“Great saves and big disasters” – Review of challenging cases and complications

Moderator:

Giancarlo Biamino, Jean-Paul de Vries

Panel:

Sebastian Sixt, Antonio Micari, Hans Krankenberg, Dai-Do Do, Sean Lyden

live from Leipzig:

Andrej Schmidt
1. Join us for brunch, served from 08:45am until 11:00am
2. Announcement of the winners of the LINC 2020 poster award
3. PERIPHERAL
4. Review of a large series of endovascular stuck catheter removal adopting a personal combination of techniques
5. Management of vascular complications during TAVI
6. Endovascular therapy for CFA disease: Case presentation and discussion of data
7. Management of popliteal aneurysms, bypass vs. stenting
8. Endovascular repair of a large pseudoaneurysm of anterior tibial artery following total knee replacement

Room 4 - Discussion Forum

8 events

Tuesday, January 28th: 12:30 - 13:25, Room 4 - Discussion Forum

Lunch symposium: My guidewire algorithm for successfully crossing peripheral lesions

supported with an educational grant from Asahi Intecc

Moderator:

Roberto Ferraresi

Discussant:

Koen Deloose, Daniel van den Heuvel, Tatsuya Nakama
1. 12:30 - 12:45
  
  Guidewire technology in the fem-pop area – the next level
2. 12:45 - 13:00
  
  My guidewire algorithm for below-the-knee success
3. 13:00 - 13:15
  
  Sliding, piercing, and other techniques for below-the-ankle lesion crossing
4. 13:15 - 13:25
  
  New concept of guidewire for crossing complex lesions
Wednesday, January 29th: 9:30 - 10:45, Room 4 - Discussion Forum

JET@LINC

Moderator:

Giancarlo Biamino, Hiroyoshi Yokoi

Discussant:

Naoki Fujimura, Masahiko Fujihara, Shigeo Ichihashi, Daizo Kawasaki, Osamu Iida
1. HOW FAR SHOULD WE GO WITH AORTIC INTERVENTION FOR SUPER SENILE PATIENT?
2. Nonagenarians have good early results, comparable to octogenarians, after elective EVAR from Japanese multicenter registry
3. What is the optimal vessel preparation? The result from IGNITE study of lower limbs intervention
4. What can we do for heavy calcified lesions?
5. What have we learned from endovascular treatment in the critical limb ischemia field?
6. Impact of Paclitaxel usage on mortality after DCB treatment in patients with PAD, learn from Lutonix JPN and IN.PACT JPN study
Wednesday, January 29th: 11:00 - 12:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline: Illustrative cases with step-by-step approach – great vessels, innominate, common carotid, subclavian, and vertebral challenges

Moderator:

Raghu Kolluri

Discussant:

Peter Schneider, Sean Lyden, John Rundback, Robert Lookstein
1. How to manage tandem lesions that include the carotid bifurcation and an inflow common carotid or innominate lesion?
2. Hybrid procedures and debranching of the arch: When to do it and how
3. Subclavian revascularisation: How to handle the occluded subclavian
4. Managing the dangerous or difficult aortic arch
Wednesday, January 29th: 12:35 - 13:20, Room 4 - Discussion Forum

Lunch symposium: Real world clinical results after treatment with non-crystalline coated balloons

supported with an educational grant from Cardionovum

Moderator:

Koen Deloose

Discussant:

Michael Lichtenberg, Amine Chouiter
1. 12:35 - 12:40
  
  Introduction and learning objectives
2. 12:40 - 12:48
  
  How to limit Wash-Off Effects with Paclitaxel DCBs? The SAFEPAX® story
3. 12:48 - 12:56
  
  APERTO® efficacy in (re-)stenosis in central veins – initial cases
4. 12:56 - 13:04
  
  High risk of restenosis patients' treatment: Update on the REFLOW trial
5. 13:04 - 13:12
  
  Safety of Paclitaxel coated devices used in dialysis access: The APERTO@ trial results
6. 13:12 - 13:20
  
  Closing remarks
Wednesday, January 29th: 14:00 - 15:00, Room 4 - Discussion Forum

SITE@LINC: Aortic disaster cases: What can we learn from the expert’s nightmares?

Moderator:

Vicente Riambau, Nilo Mosquera

Discussant:

Jean-Paul de Vries, Mauro Gargiulo, Frank Vermassen, Tilo Kölbel
1. Objective: To share bad and unexpected experiences and how to deal with them. Big names can also be in trouble. Case presentations and interactive discussion
Wednesday, January 29th: 15:00 - 16:30, Room 4 - Discussion Forum

CICE@LINC: Technical review, versatility, and clinical practice review of the new Brazilian peripheral endograft

Moderator:

Armando Lobato

Discussant:

Marc Bosiers, Bruno Freitas, Enrique San Norberto-García, Nilo Mosquera
1. 15:00 - 15:12
  
  The new Solaris endograft: Main characteristics and clinical program
2. 15:13 - 15:25
  
  The Brasilian self-expandable peripheral endograft: Initial European experience
3. 15:26 - 15:38
  
  Solaris endograft: Clinical practice review
4. 15:39 - 15:51
  
  Initial experience in complex cases with Solaris self expandable cover stent
5. 15:52 - 16:04
  
  Complex thoracoabdominal aortic aneurysms
6. 16:05 - 16:30
  
  Discussion and conclusion
Thursday, January 30th: 10:00 - 11:00, Room 4 - Discussion Forum

Vascupedia@LINC: Endoleaks–case-based solutions

Moderator:

Giovanni Torsello, Vicente Riambau

Discussant:

Mauro Gargiulo, Giovanni Federico Torsello, Roberto Chiesa
1. 10:00 - 10:15
  
  Type Ia – Decision making, treatment, tips & tricks
2. 10:15 - 10:30
  
  Type Ib – Decision making, treatment, tips & tricks
3. 10:30 - 10:45
  
  Type II – Decision making, treatment, tips & tricks
4. 10:45 - 11:00
  
  Conversion to open procedure – Decision making, treatment, tips & tricks
Thursday, January 30th: 15:00 - 16:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline – The year in review: Triumph or tragedy – my most surprising case of the past year and how it changed my approach

Moderator:

Raghu Kolluri

Discussant:

Sean Lyden, William Gray, Lawrence Garcia, John Rundback
1. Aortic
2. Carotid
3. Femoro-popliteal
4. Tibial-pedal
5. This is topic-based session with illustrative cases. The speaker will present a recent case and go through a step-by-step approach with technical tips and advice on best management.

Room 5 - Global Expert Exchange

16 events

Tuesday, January 28th: 12:30 - 13:30, Room 5 - Global Expert Exchange

DGA@LINC

Moderator:

Dierk Scheinert, Michael Lichtenberg

Panel:

Rupert Bauersachs, Erwin Blessing
1. 12:30 - 12:37
  
  Welcome remarks – addressing unmet needs in CLI – President of the German Angiology Society, DGA
2. 12:37 - 12:44
  
  CLI is a threat to life and limb!
3. 12:44 - 12:51
  
  Endovascular first for CLI
4. 12:51 - 12:58
  
  RECCORD registry – healthcare research from daily routine practice
5. 12:58 - 13:05
  
  Use of atherectomy in CLI patients – current evidence
6. 13:05 - 13:12
  
  Optimal antithrombotics in CLI
7. 13:12 - 13:19
  
  Diabetic foot infection
8. 13:19 - 13:30
  
  Discussion and conclusion
Tuesday, January 28th: 13:30 - 15:00, Room 5 - Global Expert Exchange

CLI-Therapies-LINCed: Multidisciplinary case studies from centres of excellence. Tailored strategies on revascularisation and wound management

Moderator:

Steven Kum, Peter Schneider

Panel:

Roberto Ferraresi, Marco Manzi
1. 13:30 - 13:38
  
  Optimising the SFA in CLI
2. 13:38 - 13:46
  
  BAD (Big Artery Disease) and SAD (Small Artery Disease) – an appraisal of the challenges in CLI revascularisation
3. 13:46 - 13:54
  
  Angiosome interpretation – what to open, how many to open, when to stop
4. 13:54 - 14:02
  
  Learn to cross like a pro – tricks from an Italian maestro
5. 14:02 - 14:10
  
  Therapeutic solutions for BAD in CLI
6. 14:10 - 14:18
  
  Therapeutic solutions for SAD in CLI
7. 14:18 - 14:26
  
  Making CLI interventions pain free – how to administer a popliteal nerve anaesthesia before an intervention
8. 14:26 - 14:34
  
  Managing CLI wounds – 7 min pearls for the interventionlist from a wound care specialist
9. 14:34 - 15:00
  
  Discussion and conclusion
Tuesday, January 28th: 15:00 - 15:30, Room 5 - Global Expert Exchange

Steps forward in changing BTK standard of care with bioresorbable scaffolds

supported with an educational grant from Abbott Vascular

Moderator:

Brian DeRubertis, Sahil Parikh

Panel:

Steven Kum, Ramon Varcoe, Atman Shah
1. 15:00 - 15:02
  
  Introduction
2. 15:02 - 15:09
  
  Bioresorbable scaffolds to treat patients with complex CLTI – 12-month results of the DISAPEAR study
3. 15:09 - 15:16
  
  FIRST TIME DATA RELEASE: 2-year results of bioresorbable scaffold for the treatment of patients with complex infrapopliteal arterial disease
4. 15:16 - 15:23
  
  Long terms results and glimpse into the future with bioresorbable scaffolds for BTK
5. 15:23 - 15:28
  
  Discussion, question, answers
6. 15:28 - 15:30
  
  Taking home message
Tuesday, January 28th: 15:30 - 17:00, Room 5 - Global Expert Exchange

CCT@LINC: Advanced endovascular therapy in Japan – pre-recorded live cases

Moderator:

Giancarlo Biamino, Kazushi Urasawa

Panel:

Hideyuki Takimura
1. 15:30 - 15:45
  
  Video live and lecture
2. 15:45 - 16:00
  
  Video live and lecture
3. 16:00 - 16:15
  
  Video live and lecture
4. 16:15 - 16:30
  
  Video live and lecture
5. 16:30 - 16:45
  
  Video live and lecture
6. 16:45 - 17:00
  
  Discussion and conclusion
Wednesday, January 29th: 8:00 - 9:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part I)

Moderator:

Thomas Zeller, Osamu Iida

Panel:

Stanislaw Bartus
1. 08:00 - 08:20
  
  Live case transmission from Leipzig
2. FOCUS ON NEW DATA
3. 08:20 - 08:25
  
  Propensity-matched analysis in claudicants treated with a drug- coated balloon vs. PTA: 5-year mortality outcomes from a real-world study
4. 08:25 - 08:30
  
  Durability, safety, and efficacy of a drug-coated balloon for the treatment of peripheral arterial disease in the SFA
5. 08:30 - 08:35
  
  IN.PACT global study 4-year outcomes
6. 08:35 - 08:40
  
  Results of the Illumenate EU-Global 3-year results
7. 08:40 - 08:45
  
  12-month full cohort analysis from the KANSHAS 1 study of the novel KANSHAS drug-coated balloon for treatment of femoropopliteal occlusive disease
8. 08:45 - 08:50
  
  Prestige pilot: Phoenix atherectomy and Stellarex DCB clinical investigation in infrapopliteal interventions
9. FOCUS ON CROSSING AND VESSEL PREP
10. 08:50 - 08:55
  
  Trans-radial artery access for lower limb interventions: Will dedicated new tools making this approach the future standard of care?
11. 08:55 - 09:00
  
  Retrograde crossing of peripheral occlusions: Long-term results and outcome predictors
12. 09:00 - 09:05
  
  AMBUVASC: A RCT comparing conventional vs. ambulatory of endovascular procedures of lower extremity peripheral artery disease
13. 09:05 - 09:10
  
  Dissections: Do they matter and how can they be managed?
14. 09:10 - 09:15
  
  The versatility of directonal atherectomy to address challenges of multi-level disease in CLI
15. 09:15 - 09:20
  
  Combination therapy to optimize your outcomes when treating SFA disease: Valuable tools to get the job done
16. 09:20 - 09:30
  
  Discussion and conclusion
Wednesday, January 29th: 9:30 - 10:30, Room 5 - Global Expert Exchange

Controversies and best practices for successful iliofemoral venous stenting outcomes

supported with an educational grant from COOK Medical

Moderator:

Rick de Graaf

Panel:

Michael Lichtenberg, Stephen Black, Marta Ramírez Ortega
1. 09:30 - 09:35
  
  Introduction
2. 09:35 - 09:45
  
  Stent shape is most important in achieving successful clinical outcomes
3. 09:45 - 09:55
  
  Stent conformibility is most important in achieving successful clinical outcomes
4. 09:55 - 10:05
  
  Maximizing clinical outcomes through optimizing post prodcedural care
5. 10:05 - 10:15
  
  Clinical outcomes of the Zilver Vena™ stent in a private practice setting
6. 10:15 - 10:30
  
  Discussion and conclusion
Wednesday, January 29th: 10:30 - 11:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part II)

Moderator:

George Adams, Erwin Blessing

Panel:

Miguel Montero-Baker, Marc Bosiers, Steven Kum
1. 10:30 - 10:55
  
  Live case transmission from Leipzig
2. FOCUS ON CLI/BTK
3. 10:55 - 11:00
  
  First-in-man experience with the MotiV Bioresorbable scaffold in below-the-knee arteries
4. 11:00 - 11:05
  
  Treating CLI patients with drug-coated balloons: 12-month outcomes from a real-world study
5. 11:05 - 11:10
  
  Patterns of calcification in BTK arteries
6. 11:10 - 11:15
  
  Use of directional atherectomy where stenting is not an option
7. 11:15 - 11:20
  
  Hybrid atherectomy: 1-year results from a real-world study
8. 11:20 - 11:25
  
  Comparison of procedural and long-term clinical outcomes in critical limb ischemia patients following endovascular treatment in the LIBERTY 360 study
9. 11:25 - 11:30
  
  12-month results of the DISAPEAR registry of BVS in CLI from Singapore
Wednesday, January 29th: 11:30 - 12:30, Room 5 - Global Expert Exchange

CCT@LINC – Various techniques to recanalise CTO

Moderator:

Ralf Langhoff, Kazushi Urasawa
1. 11:30 - 11:40
  
  Duplex ultrasound guided wire
2. 11:40 - 11:50
  
  Role of below-the-ankle intervention
3. 11:50 - 12:00
  
  Asahi style for complex lesions
4. 12:00 - 12:10
  
  Various EVT techniques for long SFA CTOs
5. 12:10 - 12:20
  
  Distal punctures and related techniques
6. 12:20 - 12:30
  
  Question and answers
Wednesday, January 29th: 12:30 - 13:30, Room 5 - Global Expert Exchange

Lunch symposium: Achieving quality & predictable outcomes in treatment of venous thromboembolism

supported with an educational grant from BTG, now a part of Boston Scientific

Moderator:

Nils Kucher

Panel:

Mert Dumantepe, Stefan Stortecky
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:50
  
  How to achieve only 6% PTS in the treatment of acute DVT. What device to use when?
3. 12:50 - 13:05
  
  Treatment of chronic DVT with EKOS™: Reproducing ACCESS PTS data in everyday clinical practice
4. 13:05 - 13:20
  
  Effective treatment for high risk and intermediate-high risk pulmonary embolism patients with Acoustic Pulse Thrombolysis™: Data from Bern
5. 13:20 - 13:30
  
  Discussion and conclusion
Wednesday, January 29th: 13:30 - 14:30, Room 5 - Global Expert Exchange

Deep dive session: Venous interventions (part I) Focus on diagnosis of venous obstructions, crossing of venous occlusions, and thrombus removal

Moderator:

Robert Lookstein, Nils Kucher

Panel:

Stephen Black, Erin Murphy
1. 13:30 - 13:37
  
  Well-recognized venographic signs of significant iliac vein compression in asymptomatic young volunteers
2. 13:37 - 13:44
  
  FIRST TIME DATA RELEASE: IVUS vs. fluoroscopic guided recanalisation for iliofemoral obstruction: Effective option to reduce radiation exposure during intervention
3. 13:44 - 13:51
  
  Overlap syndromes in leg swelling, special focus on elevated central venous pressure
4. 13:51 - 13:58
  
  The role of CT and MRI imaging for planning of venous procedures
5. 13:58 - 14:05
  
  Meta-analysis on thrombolysis vs. mechanical thrombectomy for iliofemoral DVT: Safety concerns should stop CDT
6. 14:05 - 14:12
  
  Optimal techniques for single session pharmaco-mechanical thrombectomy of acute deep vein thrombosis using the 8 french Rheolytic thrombectomy catheter
7. 14:12 - 14:19
  
  Safety, procedural success, and outcome of the Aspirex.S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis: Data from the Aspirex registry
8. 14:19 - 14:30
  
  Discussion and conclusion
Wednesday, January 29th: 14:30 - 15:00, Room 5 - Global Expert Exchange

Symposium: Aspirex®S in iliofemoral DVT: New evidence from multiple centres

supported with an educational grant from Straub Medical

Moderator:

Michael Lichtenberg

Panel:

Romaric Loffroy, Bruno Freitas
1. 14:30 - 14:40
  
  P-MAX study: Iliofemoral DVT. Safety and performance update from the Arnsberg cohort
2. 14:40 - 14:50
  
  Aspirex®S in iliofemoral DVT: The Dijon experience
3. 14:50 - 15:00
  
  Aspirex®S in iliofemoral DVT: The Maceio experience
Wednesday, January 29th: 15:30 - 16:30, Room 5 - Global Expert Exchange

Deep dive session: Venous interventions (part II) Focus on venous stenting

Moderator:

Rick de Graaf, Houman Jalaie

Panel:

Tim Sebastian, Matthias Ulrich
1. 15:30 - 15:36
  
  FIRST TIME DATA RELEASE: Unique challenges of iliofemoral venous obstruction: Need for venous stents with 50 year durability testing
2. 15:36 - 15:42
  
  Technical properties of nitinol: The ideal alloy for venous stenting
3. 15:42 - 15:48
  
  FIRST TIME DATA RELEASE: Impact of stent structure on venous flow
4. 15:48 - 15:54
  
  New stent design for below the inguinal ligament: The Blueflow venous stent
5. 15:54 - 16:00
  
  Abre™ IDE study: Overview of baseline demographics
6. 16:00 - 16:06
  
  Abre™ venous self expanding stent system procedure video
7. 16:06 - 16:12
  
  Predictors for patency rate and clinical improvement after iliofemoral venous recanalisation: A 228 patient cohort analysis
8. 16:12 - 16:18
  
  24-month patency rates and clinical results of the SINUS OBLIQUUS® venous stent: Data from the Arnsberg venous registry
9. 16:18 - 16:24
  
  Anticoagulation after ilio-femoral intervention
10. 16:24 - 16:30
  
  Discussion and conclusion
Wednesday, January 29th: 16:30 - 17:30, Room 5 - Global Expert Exchange

Deep dive session: Venous interventions (part III) Focus on complex venous procedures

Moderator:

Nils Kucher, Raghu Kolluri

Panel:

Tobias Hirsch, Karin Brachmann
1. 16:30 - 16:36
  
  Reconstruction of the inferior vena cava using dedicated iliofemoral venous stents: Single center experience
2. 16:36 - 16:42
  
  5 year data of acrylate treatment using Venaseal
3. 16:42 - 16:48
  
  A Singapore Venaseal real world post-market evaluation study (ASVS)
4. 16:48 - 16:54
  
  VENCLOSE™ – clinical experiences with a new radiofrequency ablation catheter
5. 16:54 - 17:00
  
  Case study highlighting patients with various venous disorders – what is the referral, diagnostics, and treatment pathway in the US
6. 17:00 - 17:06
  
  Venous ulcer – care pathway in 2020
7. 17:06 - 17:12
  
  Hybrid venous interventions: it doesn’t stop there
8. 17:12 - 17:18
  
  Review of treatment techniques for various presentations of AVMs
9. 17:18 - 17:24
  
  Onyx vs. other liquid embolic agents for AVM treatment
10. 17:24 - 17:30
  
  Discussion and conclusion
Thursday, January 30th: 9:30 - 11:00, Room 5 - Global Expert Exchange

Special course for nurses and technicians: Current concepts and new approaches in endovascular interventions. Step-by-step review of techniques and data by leading interventional experts

Moderator:

Sabine Steiner, Miguel Montero-Baker
1. FOCUS ON AORTO-ILIAC OBSTRUCTIONS
2. 09:30 - 09:37
  
  Latest techniques for crossing of aortoiliac occlusions
3. FOCUS ON FEMOROPOPLITEAL ARTERIES
4. 09:37 - 09:44
  
  The controversy about Paclitaxel coated devices – latest evidence
5. 09:44 - 09:51
  
  The retrograde approach for complex femoropopliteal and BTK obstructions
6. 09:51 - 09:58
  
  Vessel preparation in the SFA before PTA or Stenting – the role of optimal balloon angioplasty, high pressure and focal force balloons
7. 09:58 - 10:05
  
  Rotational and directional atherectomy devices: What works in which lesion?
8. 10:05 - 10:12
  
  DES vs. DCB in femoral arteries – what works best?
9. FOCUS ON BTK ARTERIES AND CLI
10. 10:12 - 10:19
  
  Calcification in BTK arteries and recanalization techniques for CTOs
11. 10:19 - 10:26
  
  The role of stents and scaffolds in BTK vessels
12. 10:26 - 10:33
  
  The concept of deep venous arterialization for end-stage CLI – current status
13. 10:33 - 11:00
  
  Discussion and conclusion
Thursday, January 30th: 11:00 - 12:30, Room 5 - Global Expert Exchange

Focus session: Advanced imaging concepts for guidance of peripheral recanalisation procedures

Moderator:

Jos van den Berg, Katja Mühlberg
1. 11:00 - 11:07
  
  Angiography alone in the lower limb: First results comparing IVUS and angiography in the leg
2. 11:07 - 11:14
  
  Towards using tissue oxygen measurements across the continuum of care for CLI management
3. 11:14 - 11:21
  
  The use of OCT in peripheral interventions: Can the Clarity of this imaging system provide better, safer outcomes? Opportunities of real-time 3D ultrasound using XL14-3 for guiding intervention in vascular disease
4. 11:21 - 11:28
  
  Value of current parameters of hemodynamic adjustment of CLI patients
5. 11:28 - 11:35
  
  Imaging the terra icognita of PAD: The microcirculation
6. 11:35 - 11:42
  
  Blood volume measurements in critical foot ischemia during interventional revascularisation: Can we predict the outcome?
7. 11:42 - 11:49
  
  Intraprocedural perfusion monitoring during lower extremity revascularisation: Outcomes from a novel system
8. 11:49 - 11:56
  
  Use of hyperspectral imaging to determine CLI and the effect of revascularisation
9. 11:56 - 12:03
  
  Assessing the clinical utility of on-table tissue oxygen monitoring for endovascular revascularisation procedures
10. 12:03 - 12:10
  
  Case reviews of tissue oxygen monitoring during endovascular revascularisation: experience at Dendermonde
11. 12:10 - 12:30
  
  Discussion and conclusion
Thursday, January 30th: 13:30 - 15:00, Room 5 - Global Expert Exchange

Special course for nurses and technicians: Current concepts and new approaches in endovascular interventions. Step-by-step review of techniques and data by leading interventional experts

Moderator:

Ralf Langhoff, Michel Bosiers
1. FOCUS ON ENDOVASCULAR AORTIC REPAIR
2. 13:30 - 13:37
  
  Optimal imaging for procedural planning and guidance of procedures
3. 13:37 - 13:44
  
  How to deal with difficult aortic necks – the interventional armamentarium
4. 13:44 - 13:51
  
  Branched endografts for thoracoabdominal aneurysms
5. 13:51 - 13:58
  
  Management of ruptured aortic aneurysms
6. 13:58 - 14:05
  
  Radiation protection during endovascular procedures – focus on the eye lens
7. FOCUS ON VENOUS INTERVENTIONS
8. 14:05 - 14:12
  
  Iliac vein recanalization: When and how?
9. 14:12 - 14:19
  
  Venous ulcers: The role of interventions in the venous system
10. FOCUS ON EMBOLIZATION PROCEDURES
11. 14:19 - 14:26
  
  Principles of embolization techniques for bleeding, endoleaks and beyond
12. 14:26 - 14:33
  
  Coil embolization before EVAR and TEVAR: What is the rationale?
13. 14:33 - 15:00
  
  Discussion and conclusion

Room 6 - Speakers' corner

12 events

Tuesday, January 28th: 12:30 - 13:30, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD – aortoiliac/EVAR/carotid/AV shunt

Moderator:

Frans Moll, Stephan Duda
1. 12:30 - 12:35
  
  Clinical outcomes and prevalence of polyvascular disease with aorto iliac artery disease – 1-year results from OMOTENASHI registry
2. 12:35 - 12:40
  
  Results of the Frontier IV study with the PerQseal. fully absorbable patch based large hole vascular closure device
3. 12:40 - 12:45
  
  Percutaneous EVAR with low-profile INCRAFT – pros and cons: 12-months results from a single-center analysis
4. 12:45 - 12:50
  
  Immediate and one-month results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention system: The IRONGUARD 2 study
5. 12:50 - 12:55
  
  Accumulating long-term evidence for the MicroNet‑covered stent safety, efficacy and durability in primary and secondary stroke prevention: 5-year data from the PARADIGM-Extend prospective academic trial
6. 12:55 - 13:00
  
  OPTIMAl endovascular sequestration of high-risk carotid plaque using the CGuard™ MicroNET–covered embolic prevention stent system in consecutive patients with symptoms or signs of carotid stenosis-related brain injury: An intravascular ultrasound – controlled investigator-initiated multcentric multi-specialty study (CGuard OPTIMA)
7. 13:00 - 13:05
  
  Maturation of Ellipsys® EndoAVF for hemodialysis
8. 13:05 - 13:30
  
  Discussion and conclusion
Tuesday, January 28th: 13:30 - 15:00, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD – femoral/BTK/CLI

Moderator:

William Gray, Iris Baumgartner
1. 13:30 - 13:35
  
  DESAFINADO registry – 12-month results of the Eluvia DES in predominantly CLI
2. 13:35 - 13:40
  
  Management of de novo long femoropopliteal occlusions; plain balloon, drug coated balloon, bare metal stent; comparative study
3. 13:40 - 13:45
  
  SELUTION SLR – a Sirolimus DEB: Use of preclinical studies in predicting device safety
4. 13:45 - 13:50
  
  SELUTION SLR: Sustained Limus release DEB for long term patient benefit
5. 13:50 - 13:55
  
  First-in-man study on the clinical use and safety of the Magic Touch PTA Sirolimus coated balloon catheter in the treatment of infrainguinal peripheral arterial disease: Interim analyses
6. 13:55 - 14:00
  
  Paclitaxel-coated balloon treatment in patients with in-stent restenosis – 24 months results of the real-world all-comers registry BIOLUX P-III
7. 14:00 - 14:05
  
  Drug coated balloon supported Supera stent vs. Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID trial
8. 14:05 - 14:10
  
  The impact of FAilure VIABAHN for femORopoplITeal lesions TRIAL (FAVORITE TRIAL)
9. 14:10 - 14:15
  
  DiRrectional AthErectomy + Drug CoAted BaLloon Angioplasty to Treat Long, CalcifiIed FemoropopliTeal ArterY lesions: Interim results from the REALITY study
10. 14:15 - 14:20
  
  Transverse View Area Loss (TVAL): An informative angiographic outcome in below-knee lesions
11. 14:20 - 14:25
  
  TANGO trial 6-month results for adventitial temsirolimus delivery below-the-knee
12. 14:25 - 14:30
  
  Everolimus eluting coronary stents for long infra-popliteal lesions for critical limb ischemia: LONG DES-BTK. A 10-year single center experience with long-term follow-up
13. 14:30 - 14:35
  
  Impact of pedal arch revascularisation on clincil outcomes of diabetic patients with critical limb ischemia

Notice

LINC 2020 programme

LINC 2020 programme

https://leipzig-interventional-course.live/

LINC LIVE webinar – Complex femoropopliteal lesions & new treatment options – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany Long SFA occlusion to P2

Introductions

Challenges of complex femoropopoliteal lesions & disease patterns – how to approach & crossing strategies

Optimal strategies for vessel preparation

Refining atherectomy with Rotarex

Real World Results, The Leipzig Experience

Discussion – Q & A – Voting

LINC LIVE webinar – Advanced concepts for complex femoropopliteal obstructions: Differential use of drug-eluting devices and the role of vessel preparation – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany Recanalisation of a challenging multilevel peripheral lesion

Latest information from the Ranger DCB programme: How does low-dose DCB technology COMPARE?

Insights on ELUVIA from the IMPERIAL-trial and beyond: When to prefer a stent-based approach?

SFA vessel preparation with the JETSTREAM atherectomy: Tips, tricks, and clinical outcomes

Atherectomy in distal disease and in-stent restenosis: expanded use learnings

Discussion – Q & A – Voting

https://leipzig-interventional-course.live/

LINC LIVE webinar – Lower limb treatment algorithm – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany – Complex lower limb cases

Treatment-algorithm femoro-popliteal artery

Embolic protection in the peripherals

Discussion – Q & A – Voting

https://leipzig-interventional-course.live/

LINC LIVE webinar – From the front line: strategies for limb preservation and reducing reintervention – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany

Introduction

Patients at risk for restenosis in today’s environment: what is your algorithm for reducing re-intervention?

Discussion

Scientific evidence for the treatment of anatomically challenging lesions

Discussion

Preserving the native vessel for future treatment options

Discussion

Algorithm for below the knee disease when stenting is not an option

Closing

https://leipzig-interventional-course.live/

LINC LIVE webinar – Use of Rotarex®S and DCB for treating ISR around the world – https://leipzig-interventional-course.live/

Evolution and challenges of ISR – how to approach

Technical aspects of Rotarex®S device

With continuous live case transmission from University Hospital Leipzig, Germany – SFA ISR

Use of Rotarex®S and DCB for ISR: French multicentre experience

Use of Rotarex®S and DCB for ISR: Beijing experience

Use of Rotarex®S and DCB for ISR: Leipzig experience

Panel Discussion

https://leipzig-interventional-course.live/

LINC LIVE webinar – Achieving confidence and best patients' outcomes for SFA lesions, with the support of your colleagues – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany – Complex treatments – simple decisions

Introduction

TIPS AND TRICKS FOR BEST INTERWOVEN NITINOL STENT RESULTS

My learnings – tips and tricks when starting with Supera

Next steps in my Supera experience

Using Supera in the most challenging situations

Discussion – Q & A – Voting

https://leipzig-interventional-course.live/

LINC LIVE webinar – Challenging lesions – Advanced technology. Utilising scoring balloons or drug coated technology – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany

Lutonix BTK registry 2 year follow up – data presentation

DCB IDE below-the-knee six-month results with in-depth look at diabetic patients

Lesion preparation with scoring technology and using a low profile access sheath in patients with CLI

The UltraScore™ focused force PTA balloon: update of a multi-centre registry

Discussion – Q & A – Voting

https://leipzig-interventional-course.live/

LINC LIVE webinar – Challenging lesions and how to approach with advanced technologies – https://leipzig-interventional-course.live/

With continuous live case transmission from University Hospital Leipzig, Germany

Optimizing vessel preparation and outcomes with debulking techniques

Japan update: Optimal strategies for vessel preparation and DCB usage

Update on Paclitaxel safety from the results of Japanese patients analysis

Discussion – Q & A – Voting

https://leipzig-interventional-course.live/

Room 1 - Main Arena 1

Symposium: Stepping forward: Changing the standard of care in lower limb treatments

Welcome

Mimetic stent technology – providing safe, sustained, and optimal care

Live case transmission from Leipzig

Supersub II – preliminary results

STELLA Supera – 12-month results revealed

Live case transmission from Leipzig

Supera VMI-CFA study – 2-year follow-up, ready to change the standard of care?